Give Online: Help shape patient care for generations to come.
Cleveland Clinic Logo

Appointments

Request an Appointment

Cancer Answer Line:
866.223.8100

M-F 8 a.m. - 4:30 p.m. ET

Expand Content

Radiation Oncology Residency


We offer a fully ACGME-accredited four year advanced training program in radiation oncology.  Residents matching at our program are required to complete a separate ACGME-accredited intern year prior to beginning their radiation oncology training.

This superior academic and clinical training program is equipped with the latest radiotherapy and radiosurgery technology and designed to prepare our residents to become future leaders in the practice of radiation oncology.

Cleveland Clinic is a large tertiary care medical center. Accordingly, there is ample clinical experience for residents in training. Residents are exposed to a variety of malignancies and treatments during their training. The department has 2 CT simulators, along with 6 linear accelerators treating up to 150 patients per day.

Experience in intensity modulated radiation therapy (IMRT), Gamma Knife Radiosurgery, stereotactic body radiotherapy (lung, spine, liver, prostate), permanent prostate seed brachytherapy (~7-8 cases/week), total body irradiation, high dose rate brachytherapy, hyperthermia, radioimmunotherapy, and intraoperative radiation are an integral part of Cleveland Clinic's program.

Pediatric experience is gained throughout training and during a dedicated month rotation at St. Jude Children's Research Hospital during the PGY-4 or 5 year.

Curriculum


PGY 2-PGY 5 (Radiation Oncology)
PGY 2

During the PGY-2 year, new resident are immersed in introductory physics and radio-biology course work in addition to exposure to the fundamentals of radiation oncology. Areas covered include work-up, treatment planning process, delivery of radiation and follow up of patients receiving radiotherapy.

PGY 3

During the PGY-3 year, the residents are expected to improve their understanding of all aspects of radiation oncology, especially the treatment planning process, and also to develop a research interest for the following year.

PGY 4

During the PGY-4 year, residents are expected to perform clinical or basic science research for 6-9 months under the supervision of an appropriate Cleveland Clinic faculty member. The remaining time will be spent in electives such as dosimetry and community radiation oncology. One member of the PGY-4 class is selected by the faculty to serve as Chief Resident.

PGY 5

During the PGY-5 year, the level of responsibility is increased. The year is structured to consolidate clinical skills and the knowledge base acquired during the previous three years.

Teaching Conferences

Resident teaching conferences are held daily between 8:00-9:00 am and are staffed by radiation oncology attending physicians and medical physicists. Residents are exempt from clinical duties during these times.

Morning Conference

Case presentation and discussion of a specific disease site, twice per week. Residents and staff discuss anatomy, work-up, imaging, treatment options, and field design. Residents are expected to study and a handout is distributed at the conclusion of the meeting.

Chart Rounds

A conference to discuss the set-up, planning, and techniques of radiation delivery.

Physics and Radiation Biology Lectures

Weekly interactive lectures in physics and radiation biology are given by faculty members for residents in the PGY-2 to PGY-4 years.

Journal Club

Monthly meetings to discuss recent articles in the field.

Radiation Oncology Grand Rounds

Bi-weekly lunch time educational sessions, conferences led by faculty members or residents.

Tumor Board

Regularly scheduled multidisciplinary conferences, attended by medical oncology, surgery, and radiation oncology in the areas of lung, breast, CNS, head & neck, gynecology, gastroenterology, and lymphoma.

Visiting Professor Program

At least four times per year, leaders in radiation oncology are invited to spend a day at Cleveland Clinic. Usually, the invited professor will give a lecture and then spend the morning discussing specific cases or issues in radiation oncology with residents.

Research & Meetings

Resident research activity can begin early at Cleveland Clinic. Although there is a dedicated 6-9 months of research time in the PGY-4 year, many junior residents have oral or poster presentations at national meetings such as ASTRO, ASCO, RSNA, AUA, and SNO.

Cleveland Clinic allows residents to attend a meeting of their choice starting in the PGY-2 year. All residents in their PGY-3, 4, and 5 year typically attend ASTRO.

Additional funding is available within the department for residents who present research at other national meetings.

Benefits
  • Vacation: 15 days (3 weeks) per year + variable number of meeting days and institutional holidays
  • Call Schedule: Home call, one week at a time.
  • Book fund: An individual book fund is available for all residents to purchase texts.
  • Office space: Each resident has personal desk space with a computer and dual monitors. The residents' room is on the 2nd floor (windows!).
  • Pagers: Cleveland Clinic has a text paging system.

There are typically three positions available per year. Cleveland Clinic and the Radiation Oncology Program participate in the Electronic Residency Application Service (ERAS) for the application process and the National Resident Matching Program (NRMP) for the matching of residents to programs.

The internship year is no longer incorporated into the residency program at CCF. Therefore, applicants who match at Cleveland Clinic for radiation oncology residency must complete a separate intern year in an ACGME-accredited program.

Interviews

Applications will be reviewed upon completion and selected candidates will be invited for interviews. Candidates selected for interviews will be notified in November and interviews will typically occur on Mondays in January. The interview schedule begins with an informal evening with the residents at a local restaurant. This is an opportunity for the applicants to get to know the residents and ask questions.

Each candidate is provided with an individualized timetable for their interview day (typically Monday). For all candidates, this includes a program overview over breakfast with the program director at approximately 7:30 am, morning conference beginning at 8:00 am, after which applicants interview with various members of the department. Each candidate will meet with 6-9 faculty members on interview day, including the Chairman, the Program Director, and the Chief Medical Physicist. Interviewees are also given an opportunity to spend some time in the clinic. Prior to completing their final interviews, applicants have another chance to get to know the residents during the informal interview day lunch. The day typically concludes around 2:00 pm, although schedules may vary.

Note

Cleveland Clinic subsidizes a proportion of accommodation fees.

Elective Medical Student Rotations

Fourth year medical students interested in an elective rotation in the Department of Radiation Oncology should contact Danielle Berry regarding availability at berryd2@ccf.org or by phone at 216-445-4379.

Further information about medical student elective rotations at Cleveland Clinic, including requirements, eligibility and the application form can be viewed at the Cleveland Clinic Medical Student Elective Website.

Students who perform electives at Cleveland Clinic are often expected to function as independent residents. Responsibilities include evaluation of patients, dictation, and presentation of a morning conference. Both research and clinical electives are available.

Contact Information

You may obtain additional information about the Radiation Oncology Residency Program by contacting:


Danielle Berry

Department of Radiation Oncology
Cleveland Clinic
9500 Euclid Avenue T-28
Cleveland, OH 44195
Phone: 216.445.4379
Email: berryd2@ccf.org

PGY-5

Neil Woody, MD

Hometown: Toronto, Canada

Medical School: Cleveland Clinic Lerner College of Medicine

Hobbies: Hiking, canoeing, hockey

Why did you choose Cleveland Clinic? The dedicated intern year is structured to allow rotations through radiation related specialties and get to know the clinic and referring physicians. There are dedicated conferences for resident education daily. The mentorship model working directly one on one with a single staff member at a time who is passionate about resident education. Co-residents who are friendly, fun and motivated to add to each other’s learning.


Mike Weller, MD

Hometown: Orlando, FL

Medical School: University of Miami School of Medicine

Hobbies: I'm an ACC sports fan marooned Big 10 country. I love to travel, spend too much money at restaurants, and watch way too many movies and TV shows. Most importantly, I love spending time hanging out with my wife and playing with our dog.

Why did you choose Cleveland Clinic? Aside from all of the benefits associated with training in a world class hospital and cancer center, I believe our faculty's uncompromised dedication to resident teaching is truly unique.


Jeff Kittel, MD

Hometown: Wilton, CT

Medical School: Washington University in St. Louis

Hobbies: Baseball, Cleveland's amazing microbrewery scene, the West Side Market, biking

Why did you choose Cleveland Clinic? The family-like relationship among the residents, our excellent educational curriculum, and the chance to learn from amazing teachers


Steven Oh, MD

Hometown: Portland, OR

Medical School: Yale

Hobbies: Boxing, Snowboarding, Surfing, Tennis, Traveling

Why did you choose Cleveland Clinic? For the best group of faculty and residents to work with.

PGY-4

Matt Ward, MD (Chief Resident)

Hometown: Alpharetta, GA

Medical School: Medical College of Georgia

Hobbies: Teasing Rupesh, traveling, reading, camping, whitewater, snowboarding, hanging out with my wife

Why did you choose Cleveland Clinic? I chose Cleveland Clinic partly for the excellent clinical experience but mostly because of the cordial atmosphere with a strong dedication to resident education. I chose Cleveland because the Cleveland Clinic is here. I have enjoyed Cleveland’s diverse communities, restaurants and music.


Yvonne Thanh-Nga Pham, MD

Hometown: Orange County, CA

Medical School: University of California at Davis- Sacramento, CA

Hobbies: Beginner golfer. I also enjoy tennis, running, traveling and photography.

Why did you choose Cleveland Clinic? The specialty tailored intern year at Cleveland Clinic gives you great hands-on experience with the medical and surgical fields related to radiation oncology. You have a chance to assist with relevant oncologic surgeries and follow patients in their post-op recovery. On the Heme/Onc and palliative rotations, you learn about pain management and how to care for patients in the context of their cancer. The breadth of exposure to these related fields has been invaluable to my training


Rupesh Kotecha, MD

Hometown: Midland, MI

Medical School: MSU College of Human Medicine

Hobbies: Spending more time at Cheesecake Factory than at the hospital, Playhouse Square, Cleveland Orchestra

Why did you choose Cleveland Clinic? The focus of the department and the staff on resident education and the residency program.

PGY-3

Ehsan Balagamwala, MD

Hometown: St. Louis, MO

Medical School: Cleveland Clinic Lerner College of Medicine

Hobbies: Photography, traveling, basketball

Why did you choose Cleveland Clinic? My decision to pursue residency training at Cleveland Clinic was influenced by our faculty’s incredible dedication to education, balanced approach to clinical service and education, the collegiality of the residents and the excellent research opportunities. One of the other strengths of our program is the integrated intern year which exposes interns to a wide variety of oncologic specialties integrating us into oncology from day 1 and providing exposure to (an opportunity to learn from) referring doctors and specialties. In terms of patient population, we get exposed to a good mix of bread-and-butter cases as well as once-in-a-lifetime type of cases thereby giving us not only breadth but also depth in our educational experience.


Camille Berriochoa, MD

Hometown: Boise, ID

Medical School: University of Washington School of Medicine

Hobbies: Running, mountain biking, hiking, skiing, traveling, learning Spanish, salsa dancing, reading, cooking, hosting dinner parties, baking

Why did you choose Cleveland Clinic? The Cleveland Clinic radiation oncology program provides training that is both rigorous and nurturing at the same time. The attending physicians are here not only to provide excellent clinical care but to push their trainees to gain a deep understanding of radiation oncology and cancer management in general. Additionally, my co-residents are kind, fun, easygoing, and incredibly helpful. In terms of the city itself, this is a place that offers big city activities without the associated hassle. From its world renowned symphony to its numerous Broadway offerings, multiple professional sports teams (records aside!), and delicious restaurants, there are myriad activities to enjoy. I greatly look forward to spending four more years here.


Charles Marc Leyrer, MD

Hometown: Cary, NC

Medical School: Wake Forest

Hobbies: Reading, cooking, snowboarding, board games, racquetball, home-brewing, golfing, camping

Why did you choose Cleveland Clinic? I decided to come here after doing my away rotation here. The program itself was tough but it was in the name of making you a great evidence-based physician and I knew it was a program that would help me excel. The dedicated intern year was a great in that it allowed you interaction with many other specialties with opportunities you might not normally have access to. The main reason I came here was the residents were very welcoming and supportive of each other and they were the kind of group I wanted to be part for my residency.

PGY-2

Aditya Juloori, MD

Hometown: Houston, TX

Medical School: Baylor College of Medicine, TX

Hobbies: Obsessing over the NBA (especially my Houston Rockets), traveling, trying new food and drink, reading, good TV

Why did you choose Cleveland Clinic? I chose Cleveland Clinic because it has a great group of supportive faculty and residents with a fantastic, cohesive atmosphere. The faculty is committed to resident education first and foremost along with outstanding research opportunities. There's a history here of producing incredibly thoughtful, well-rounded oncologists. The focus on evidence-based medicine and resident didactics was something that really appealed to me. CCF stood out to me on my interview day as having a group of people - from the residents to the staff to the attending - who really seemed to care.


Bindu Manyam, MD

Hometown: Detroit, MI

Medical School: Case Western Reserve University School of Medicine, OH

Hobbies: Working out, tennis, trying new restaurants in Cleveland, binging on Netflix, traveling

Why did you choose Cleveland Clinic? I chose Cleveland Clinic because I feel it is the best residency training program. The faculty are truly invested in resident education and challenge the residents to be excellent radiation oncologists, both clinically and academically. I especially appreciate the close-knit atmosphere of the department and that my fellow residents are fun, intelligent, and dependable. I've been in Cleveland for many years and love that it has all the perks of a big city, without the hassle.

Recent Graduates from the Radiation Oncology Residency Program
Former Resident Medical School Current Position
Jason Hearn, MD (2015)
Harvard Medical School Boston, MA University of Michigan Ann Arbor, MI
Gaurav Marwaha, MD (2015)
University of Cincinnati College of Medicine, OH Rush University Medical Center Chicago, IL
Mihir Naik, DO (2015)
Midwestern University, Chicago College of Osteopathic Medicine, IL Cleveland Clinic Florida Weston, FL
Arya Kumar, MD (2014) Case Western Reserve University School of Medicine, Cleveland, OH University Hospitals, Cleveland, OH
Monica Shukla, MD (2014) Vanderbilt University School of Medicine, Nashville, TN Medical College of Wisconsin, Milwaukee, WI
Susan Guo, MD (2013) Columbia University, New York, NC Albuquerque, NM
Abigail Stockham, MD (2013) University of Iowa, Iowa City, IA Mayo Clinic, La Crosse, WI
Grant Hunter, MD (2012) University of Virginia, Charlottesville, VA Intermountain Healthcare, Salt Lake City, UT
Lawrence Sheplan, MD (2012) University of Puerto Rico, San Juan, Puerto Rico San Juan, Puerto Rico
Shlomo Koyfman, MD (2011) Yale University, New Haven, CT Cleveland Clinic, Cleveland, OH
Mohammad Khan, MD, PhD (2011) University of Tennesse, Memphis, TN Emory University Hospital, Atlanta, GA
Michael Burdick, MD (2010) Virginia Commonwealth University, Richmond, VA Valley Medical Oncology Consultants; Pleasanton, CA
Erin Murphy, MD (2010) Case Western Reserve University, Cleveland, OH Cleveland Clinic, Cleveland, OH
Andrew Vassil, MD (2010) University of Medicine and Dentistry of New Jersey, New Brunswick, NJ Cleveland Clinic, Cleveland, OH
Clifford Robinson, MD (2009) Case Western Reserve University, Cleveland, OH Washington University, St. Louis, MO
Kevin Stephans, MD (2009) Case Western Reserve University, Cleveland, OH Cleveland Clinic, Cleveland, OH
Carryn Anderson, MD (2008) U. Texas Medical Branch, Galveston, TX University of Iowa, Iowa City, IA
Rahul Tendulkar, MD (2008) University of Michigan, Ann Arbor, MI Cleveland Clinic, Cleveland, OH
Heath Mackley, MD (2007) University of Pennsylvania, Philadelphia, PA Penn State Hershey Medical Center, Hershey, PA
Justin Juliano, MD (2007) SUNY Upstate, Syracuse, NY Penn State Hershey Medical Center, Hershey, PA
Samuel Chao, MD (2006) Case Western Reserve University, Cleveland, OH Cleveland Clinic, Cleveland, OH
Vipul Thakkar, MD (2006) University of Florida, Gainesville, FL Southeast Radiation Oncology Group, Charlotte, NC
Ratna Sajja, MD (2005) Case Western Reserve University, Cleveland, OH Cancer Care Associates, McKinney, TX
Aimee Quan, MD (2005) University of Cincinnati, Cincinnati, OH Kaiser / Los Angeles Medical Center, Los Angeles, CA
Tom Carlson, MD (2004) University of Arizona, Tucson, AZ Wenatchee Valley Medical Center, Wenatchee, WA
Deepak Khuntia, MD (2004) University of Illinois at Chicago, Chicago, IL Varian Medical Systems, Palo Alto, CA
Chandrika Patel, MD (2003) Washington University, St. Louis, MO St. John Cancer Center, Anderson, IN
Mohammad El Shaikh, MD (2003) Ain Shams University, Cairo, Egypt Henry Ford Health System, Detroit, MI
Jeffrey Buchsbaum, MD, PhD. (2002) Johns Hopkins University, Baltimore, MD Indiana University Midwest Proton Center, Indianapolis, IN
Jason Seavolt, MD (2002) Medical College of Ohio, Toledo, OH Riverside Methodist Medical Center, Columbus, OH
Teresa Davies-Johns, MD (2001) NE Ohio Univ. College of Medicine, Rootstown, OH  
Lav Goyal, MD (2001) Case Western Reserve University, Cleveland, OH Associates in Radiation Oncology, Parkland, FL
Mark Chidel, MD (2000) University of Michigan, Ann Arbor, MI Summit Radiation Oncology, Littleton, CO
Janice Lyons, MD (2000) Chicago Medical School, Chicago, IL University Hospitals Case Comprehensive Cancer Center, Cleveland, OH
Publications and Presentations 2014

Academic activities in Radiation Oncology

PUBLISHED PAPERS/MONOGRAMS:

  1. Ahmed Z, Balagamwala E, Murphy E, Angelov L, Suh J, Lo S, Chao S. CNS Oncology Mini-Review: Postoperative stereotactic radiosurgery for resected brain metastasis. CNS Oncol 3:199-207, 2014.
  2. Abelson B, Reddy CA, Ciezki JP, Angermeier K, Ulchaker J, Klein EA, Wood HM. Outcomes after photoselective vaporization of the prostate and transurethral resection of the prostate in patients who develop prostatic obstruction after radiation therapy. Urology 83:422-427, 2014.
  3. Ahluwalia MS, Vogelbaum MV, Chao ST, Mehta M. Brain metastasis and treatment. F1000Prime Reports 6:114, 2014.
  4. Al-Khudari S, Guo S, Chen Y, Nwizu T, Greskovich JF, Lorenz R, Burkey BB, Adelstein DJ, Koyfman SA. Solitary dural metastasis at presentation in a patient with untreated human papillomavirus associated squamous cell carcinoma of the oropharynx. Head Neck 36(10):E103-5, 2014.
  5. Amoush A, Wilkinson A. Low dose rate brachytherapy for prostate cancer at the Cleveland Clinic: A technical review. Appl Rad Oncol Feb 2014.
  6. Babcook MA, Sramkoski RM, Fujioka H, Daneshgari F, Almasan A, Shukla S, Nanavaty RR, Gupta S. Combination of simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells. Cell Death & Disease, 2014: 5: e1536; PMID: 25412314.
  7. Balagamwala EH, Djemil T, Koyfman SA, Chao ST, Angelov L, Suh JH, Xia P. Repeat stereotactic body radiotherapy for recurrent spinal tumors is feasible with accurate assessment of cumulative spinal cord dose. J Radiat Oncol 3:185-193, 2014
  8. Chang JY, Kestin LL, Barriger RB, Chetty IJ, Ginsburg ME, Kumar S, Loo, Jr, BW, Movsas B, Rimner A, Rosenzweig KE, Stinchcombe TE, Videtic GMM, Willers H. ACR Appropriateness Criteria® Nonsurgical Treatment for Locally Advanced Non–Small-Cell Lung Cancer: Good Performance Status/Definitive Intent. Oncology Journal, Lung Cancer, Radiat Oncol 706-722, Aug 2014.
  9. Chao ST, Meier T, Hugebeck B, Reddy CA, Godley A, Kolar M, Suh JH. Workflow Enhancement (WE) Improves Safety in Radiation Oncology: Putting the WE and Team Together at Cleveland Clinic. Int J Radiat Oncol Biol Phys 89:765-772, 2014.
  10. Ciezki JP. In reply to Jones and Menon. Int J Radiat Oncol Biol Phys 89(4):930-1, 2014
  11. Chipman JJ, Sanda MG, Dunn RL, Wei JT, Litwin MS, Crociani CM, Regan MM, Chang P; PROST-QA Consortium. Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice. J Urol. 2014 Mar;191(3):638-45
  12. Fang X, Huang Z, Zhou W, Wu Q, Sloan AE, Ouyang G, McLendon R, Yu JS, Rich JN, Bao S. The Transcription Factor ZFX Is Required for Maintaining the Tumorigenic Potential of Glioblastoma Stem Cells. Stem Cells 32:2033-2047, 2014.
  13. Guo S, Balagamwala EH, Reddy C, Elson P, Chao ST, Videtic GM, Suh JH. Clinical and Radiographic Outcomes from Repeat Whole Brain Irradiation for Brain Metastases in the Age of Stereotactic Radiosurgery. Am J Clin Oncol Mar 2014 Epub
  14. Ha D, Stephans K, Choi H; Zell K, Wang X, Minai OA, Raymond DP, Videtic G, and Mazzone PJ. Heart rate recovery and survival in patients undergoing stereotactic body radiotherapy for treatment of early-stage lung cancer. Journal of Radiosurgery and SBRT. 3(3):193-201, 2014.
  15. Hara W, Koyfman SA. General principles of radiation therapy for head and neck cancer. UpToDate. Dec 2014
  16. Hearn JWD, Videtic GMM, Djemil T, Stephans KL. Salvage Stereotactic Body Radiotherapy (SBRT) for Local Failure after Primary Lung SBRT. Int J Radiat Oncol Biol Phys 90:402-406, 2014.
  17. Hong T, Pretz J, Suh W, Herman J, Abdel-Wahab M, Azad N, Blackstock AW, Das P, Goodman K, Jabbour S, Jones WE, Konski A, Koong AC, Rodriguez-Bigas M, Small W, Thomas CR, Zook J. Anal Cancer Expert Panel on Radiation Oncology–Rectal/Anal cancer: http://www.acr.org 2014
  18. Hong TS, Bosch WR, Krishnan S, Kim TK, Mamon HJ, Shyn P, Ben-Josef E, Seong J, Haddock, MG, Cheng JC, Feng MU, Stephans KL, Roberge D, Crane C, and Dawson, LA. Interobserver variability in target definition for Hepatocellular Carcinoma (HCC) with and without portal vein thrombus: Radiation Therapy Oncology Group consensus guidelines. Int J Radiat Oncol Biol Phys 89(4):804-13, 2014.
  19. Jan N, Balik S, Hugo GD, et al. Interfraction displacement of primary tumor and involved lymph nodes relative to anatomic landmarks in image guided radiation therapy of locally advanced lung cancer. Int J Radiat Oncol Biol Phys 88:210-215, 2014.
  20. Joshi N, Woody NM, Abdel Wahab M. Pre-operative chemoradiation for rectosigmoid cancers: Where do we draw the line? Appl Radiat Oncol September 2014, 24-26.
  21. Keller LN, Galloway TJ, Holdbrook T, et al. P16 status, pathologic and clinical characteristics, biomolecular signature, and long-term outcomes in head and neck squamous cell carcinomas of unknown primary. Hesd Neck 2014
  22. Kotecha R, Ward MC, Koyfman SA. Organ preservation in patients with locally advanced larynx cancer: Important principles and treatment considerations. Appl Radiat Oncol 3:26-31, 2014.
  23. Kotecha R, Angelov L, Barnett GH, Reddy CA, Suh JH, Murphy ES, Neyman G, Chao ST. Calvarial and Skull Base Metastases: Expanding the Clinical Utility of Gamma Knife Radiosurgery. J Neurosurg Suppl 121:91-101, 2014.
  24. Koyfman SA, Shukla ME, Bricker A, Djemil T, Wood B, Masaryk T, Suh JH. Stereotactic Body Radiotherapy (SBRT) for a Large Arteriovenous Malformation of the Head and Neck. Laryngoscope: 2014, Sep 8
  25. Koyfman SA, Hara W. Definitive radiation therapy alone for advanced (stage III and IV) head and neck cancer: Dose and fractionation schedule. UpToDate. Dec 2014.
  26. Kumar AMS, Woody N, Djemil T, Videtic GMM, Stephans KL. Synchronous non small cell lung cancer nodules treated with stereotactic body radiation therapy (SBRT). J Radiosurgery and SBRT 3:81-88, 2014.
  27. Leyrer M, Chan M, Peiffer A, Horne E, Harman M, Carter A, Hinson H, Mirlohi S, Duncan S, Dietrich A, Lessner G. Taste and smell disturbances after brain irradiation: A dose-volume histogram analysis of a prospective observational study. Pract Radiat Oncol 4:130-135, 2014.
  28. Liu J, Lubelski D, Schonberg D, Wu Q, Hale J, Flavahan W, Man J, Hjelmeland A, Yu JS, Lathia J, Mulkearns-Hubert E, Rich JN, Phage Display Discovery of Novel Molecular Targets in Glioblastoma Initiating Cells. Cell Death and Differentiation:1-15, 2014.
  29. Lo SS, Gore EM, Bradley JD, Buatti JM, Germano I, Ghafoori AP, Henderson MA, Murad GJ, Patchell RA, Patel SH, Robbins JR, Robins HI, Vassil AD, Wippold FJ 2nd, Yunes MJ, Videtic GM. ACR Appropriateness Criteria® Pre-Irradiation Evaluation and Management of Brain Metastases. J Palliat Med. 2014 Ju [Epub ahead of print]
  30. Mallick S, Gandhi AK, Joshi NP, Pandit S, Bhasker S, Sharma A, Mohanti B. Reirradiation in head and neck cancers: An Indian tertiary cancer centre experience J Laryngol Otol 128:996-1002, 2014.
  31. Man J, Shoemake S, Zhou W, Fang X, Wu Q, Rizzo A, Prayson R, Bao S, Rich JN, Yu JS. Sema3C Promotes The Survival and Tumorigenecity of Glioma Stem Cells Through Rac1 Activation. Cell Reports 9(5):1812-1826, 2014.
  32. Marta GN, Murphy ES, Chao ST, Yu J, Suh JH. The incidence of second brain tumors related to cranial irradiation: a systematic review. Expert Review of Anticancer Therapy 1-10, 2014.
  33. Marwaha G, Barrett WL. Stage III and IV head and neck cancer: Does everyone need chemotherapy? Intl J Otol Head and Neck Cancer 3:26-28, 2014.
  34. Marwaha G, Stephans KL, Woody NM, Reddy CA, Videtic GMM. Lung SBRT: Regional nodal failure is not predicted by tumor size. J Thorac Oncol 9:1693-1697, 2014.
  35. McNamara MJ, Adelstein DJ, Bodmann JW, Greskovich JF, Ives DI, Mason DP, Murthy SC, Rice TW, Saxton JP, Sohal D, Stephans K, Rodriguez CP, Videtic GM, Rybicki LA. A Phase II Trial of Induction Epirubicin, Oxaliplatin, and Fluorouracil, Followed by Surgery and Postoperative Concurrent Cisplatin and Fluorouracil Chemoradiotherapy in Patients with Locoregionally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction. Journal of Thoracic Oncology 9(10):1561-7, 2014.
  36. Mukherjee S, Reddy C, Ciezki J Abdel-Wahab M, Tiu R, Copelan E, Advani A, Saunthararajah Y, Paulic K, Hobson S, Maciejewski J, Bolwell B, Kalaycio M, Dreicer R, Klein E, Sekeres M. Risk of developing myelodysplastic syndromes in prostate cancer patients definitively treated with radiation. J Natl Cancer Inst. 106(3): Epub, 2014
  37. Murphy ES, Vassil N, Reddy CA, Vassil AD, Adelstein D, Mekhail T, Murthy S, Rice T, Mason D, Videtic GM. Pleural Mesothelioma treated with Induction Platinum based chemotherapy followed by Extrapleural Pneumonectomy (EPP) and Adjuvant Intensity-Modulated Radiation Therapy (IMRT): The Cleveland Clinic Experience. J Radiat Oncol 3: 159-166, 2014.
  38. Niwattisaiwong S, Suh JH, Weil RJ, Hamrahian A. Significant hypercortisolism during fractionated radiotherapy in a patient with large corticotroph adenoma: a case report and the literature review. Endocr Pract 16:1-15, 2014
  39. Page BR, Hudson AD, Brown DW, Shulman AC, Abdel-Wahab M, Fisher BJ, Patel S. Cobalt, linac, or other: what is the best solution for radiation therapy in developing countries? Int J Rad Onc Biol Phys 89:476-480, 2014.
  40. Portell C, Aronow M Rybicki L, Macklis R, Singh A, Sweetenham J. Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: Treatment outcomes in extranodal marginal zone subtype. Clin Lymphoma Myeloma Leuk 14:203-210, 2014.
  41. Qi P, Pouliot J, Roach M III, Xia P. Offline Multiple Adaptive Planning Strategy for Concurrent Irradiation of the Prostate and Pelvic Lymph Nodes. Med.Phys 41:1-6, 2014.
  42. Rodriguez CP, Adelstein DJ, Rybicki LA, Savvides P, Saxton JP, Koyfman SA, Greskovich JF, Yao M, Scharpf J, Lavertu P, Wood BG, Burkey BB, Lorenz RR, Rezaee RP, Zender CA, Ives DI. A randomized phase III study of two cisplatin based chemoradiation (CCRT) regimens in locally advanced head and neck squamous cell carcinoma (LAHNSCC): The impact of changing disease epidemiology on contemporary trial design. Head Neck. 2014 Jun 7
  43. Rosenblatt E, Abdel-Wahab M, El-Gantiry M, Elattar I, Bourque JM, Afiane M, Benjaafar N, Abubaker S, Chansilpa Y, Vikram B and Levendag PC : Brachytherapy boost in loco-regionally advanced nasopharyngeal carcinoma: a prospective randomized trial of the International Atomic Energy Agency. Radiation Oncology Radiat Oncol 9(1):67, 2014.
  44. Seastone DJ, Elson P, Garcia JA, Chao ST, Suh JH, Angelov L, Rini BI. Clinical Outcome of Stereotactic Radiosurgery for Central Nervous System Metastases From Renal Cell Carcinoma. Clin Genitourin Cancer 12(2):111-116, 2104.
  45. Sharma A, Janocha TA, Hill BT, Smith MR, Erzurum SC, Almasan A. Targeting mTORC1-mediated metabolic addiction to overcome fludarabine resistance in malignant B cells. Molecular Cancer Res. 12:1205-1215, 2014.
  46. Sharma DN, Joshi NP, Gandi AK, Haresh KP, Gupta S, Julka PK, Rath GK. High dose-rate interstitial brachytherapy for T1-T2 stage penile carcinoma: Short-term results. Brachytherapy 13:481-487, 2014.
  47. Sheehan JP, Starke RM, Kano H, Kaufmann AM, Mathieu D, Zeiler FA, West M, Chao ST, Varma G, Chiang VL, Yu JB, McBride HL, Nakaji P, Youssef E, Honea N, Rush S, Kondziolka D, Lee JY, Bailey RL, Kunwar S, Petti P, Lunsford LD. Gamma Knife radiosurgery for sellar and parasellar meningiomas: a multicenter study. J Neurosurg 120(6):1268-77, 2014.
  48. Shiue K, Barnett G, Suh J, Vogelbaum M, Reddy C, Weil R, Angelov A, Neyman G, Chao S. Using higher isodose lines for gamma knife treatment of 1 to 3 brain metastases is safe and effective. Neurosurg 74(4):360-6, 2014
  49. Singh V, Gupta D, Arora R, Tripathi RP, Almasan A, Macklis RM. Surface levels of CD20 determine anti-CD20 antibodies-mediated cell death in vitro. PLoS One. 2014, 9: e111113,
  50. Singh K, Sharma A, Mir MC, Drazba JA, Heston WD, Magi-Galuzzi C, Hansel D, Rubin BP, Klein EA, Almasan A. Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin). Molecular Cancer. 13:70, 2014.
  51. Sohal DP, Rice TW, Rybicki LA, Rodriguez CP, Videtic GM, Saxton JP, Murthy SC, Mason DP, Phillips BE, Tubbs RR, Plesec T, McNamara MJ, Ives DI, Bodmann JW, Adelstein DJ. Gefitinib in definitive management of esophageal or gastroesophageal junction cancer: a retrospective analysis of two clinical trials. Dis Esophagus May 21, 2014. [Epub ahead of print]
  52. Stancu AM, Smith MR, Almasan A. New agents for the treatment of lymphoid leukemia and lymphoma: focus on recent FDA approvals. Discoveries 2014, 2: e14
  53. Srinivas SM, Natarajan N, Kuroiwa J, Bazerbashi B, DiFilippo FP, Yu N, Shah SN, McLennan G, Obuchowski N, Determination of radiation absorbed dose to primary liver tumors and normal liver tissue using post-radioembolization 90Y PET, Frontiers in Oncology, section Cancer Imaging and Diagnosis, Vol 4, Oct 2014
  54. Stanic S, Paulus R, Timmerman R, Michalski J, Barrier R, Bezjak A, Videtic G, Bradley J. No clinically significant changes in pulmonary functionfollowing stereotactic body radiation therapy for early-stage peripheral non-small cell lung cancer: An analysis of RTOG 0236. Int J Rad Onc Biol Phys 88(5) 1092-1099, 2014
  55. Stephans KL. Editorial Comment on Intravesical Lipiodol Injection Technique for Image-Guided Radiation Therapy for Bladder Cancer). Urology 83:946-850, 2014.
  56. Stephans K, Djemil T, Diaconu C, Reddy C, Xia P, Woody N, Greskovich J, Makkar V, Videtic G. Esophageal dose tolerance to hypofractionated stereotactic body radiotherapy: Risk factors for late toxicity. Int J Radiat Oncol Biol Phys 90:197-202, 2014.
  57. Stephans, KL. Stereotactic Body Radiation (SBRT) for Lung Cancer. Appl Radiat Oncol 3(3):5-11, 2014.
  58. Swegal W, Koyfman SA, Scharpf J, Sindwani R, Greskovich JF, Borden E, Burkey BB. Endoscopic and Open Surgical Approaches to Locally Advanced Sinonasal Melanoma: Comparing the Therapeutic Benefits. JAMA Otolaryngol Head Neck Surg. 2014 Sep 1;140(9):840-5.
  59. Suh JH. Hippocampal avoidance whole-brain radiation therapy: a new standard for patients with brain metastases? Editorial. J Clin Oncol 32:3789-3791, 2014.
  60. Videtic G. Oncology scan-defining dose, fractionation, and target volume in small cell lung cancer. Int J Radiat Oncol Biol Phys 88(5) 981-983, 2014.
  61. Videtic GM. The role of stereotactic radiotherapy in the treatment of oligometastases. Curr Oncol Rep 16(7):1-6, 2014.
  62. Videtic GMM, Stephans KL, Woody NM, Reddy CA, Zhuang T, Magnelli A, Djemil T. 30 Gy or 34 Gy? Comparing Two Single-Fraction SBRT Dose Schedules for Stage I Medically Inoperable Non-Small-Cell Lung Cancer. Int J Radiat Oncol Biol Phys 90:203-208, 2014.
  63. Videtic GM, Chang JY, Chetty IJ, Ginsburg ME, Kestin LL, Kong FM, Lally BE, Loo BW Jr, Movsas B, Stinchcombe TE, Willers H, Rosenzweig KE; Expert Panel on Radiation Oncology Lung. ACR Appropriateness Criteria® Early-Stage Non-Small-Cell Lung Cancer. Am J Clin Oncol 37(2):201-207, 2014.
  64. Vossler M. A simple formula to determine the bolus thinkness on an oblique surface. Med Dos. 39 127-128, 2014
  65. Wang Y, Vassil A, Tendulkar R, Bayouth J, Xia P. Application of non-flat x-ray photons to whole-breast irradiation using direct aperture optimization. J Appl Clin Med Phys. 5: 57-64, 2014.
  66. Ward C, Tendulkar RD, Ciezki JP, Klein EA. Future Directions from Past Experience: A Century of Prostate Radiotherapy. Clin Genitourin Cancer 12(1):13-20, 2014.
  67. Weller M, Marshall K, Lovato JF, Bourland JD, deGuzman AF, Munley MT, Shaw EG, Tatter SB, Chan MD. Single-Institution Retrospective Series of Gamma Knife Radiosurgery in the Treatment of Multiple Sclerosis-Related Trigeminal Neuralgia: Factors that Predict Efficacy. Stereotactic Funct Neurosurg 92:53-58, 2014.
  68. Xiang J. Luo Q, Kotecha R, Korman A, Zhang F, Lou H, Fujiwara H, Hemasilpin N, Rose D. Accumulated source imaging of brain activity with both low and high-frequency neuromagnetic signals. Frontiers in Neuroinformatics 8:57, 2014
  69. Zhuang T, Magnelli A, Liu H, Qi P, Djemil T, Stephans K, Videtic G, Xia P. Quantify the effect of inter breath-hold motion in cone-beam CT acquired under active breathing control. J Radiat Oncol 3:321-330, 2014.
  70. Zimmerman LW, Wilkinson DA. Method for Verifying the Air Kerma Strength of Pre-Assembled I-125 Plaques for Ocular Melanoma. J Appl Clin Medical Physics 15:297-305, 2014.
PUBLISHED BOOK CHAPTERS:
  1. Chao ST, Suh JH. Up to 10 Gy. In Controversies in Radiosurgery. Eds. Gerszten P, Sheehan J. Thieme. 152-7. 2014.
  2. Jung E, Lo SS, Sahgal A, Chang EL, Suh JH, Balagamwala E, Chao ST. Chapter 1: Overview of SBRT for Spinal Metastases. In: Lo S, Sahgal A, Teh BS, Gerszten P, Chang EL. Stereotactic Body Radiation Therapy: Spinal Metastasis, 1st edition. Expert Reviews Ltd. 5-22. 2014.
  3. Lo SS, Sahgal A, Chao ST, Suh JH, Chang EL. Clinical applications: epidural spinal cord compression. Chapter 7. In: Lo S, Sahgal A, Teh BS, Gerszten P, Chang EL. Stereotactic Body Radiation Therapy: Spinal Metastasis, 1st edition. Expert Reviews Ltd 111-126. 2014.
  4. Ouzidane M, Evans J, Djemil T. Dedicated linear accelerators for stereotactic radiation therapy. In Benedict SH, Schlesinger DJ, Goetsch SJ, Kavanagh BD. Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy. CRC Press 2014
  5. Stockham AL, Balagamwala EH, Macklis R, Wilkinson A, Singh AD. Principles of Radiation Therapy. In: Clinical Ophthalmic Oncology. 89-98. 2014.
  6. Ward MC, Ciezki JP, Stephans KL. Chapter 8: Brachytherapy. In Surgical techniques for Prostate Cancer, First Edition, eds Khanna, Bratslavsky, and Stein. New York, NY, Springer 2014, pp 79-96.
EDITORS OF TEXTBOOKS:
ACCEPTED BOOK CHAPTERS:
  1. Angelov L, Chao S, Suh J. Clinical Outcomes of Pain and Quality of Life after Spinal Radiosurgery. Spine Radiosurgery, 2nd Edition,Submitted Nov 2014
  2. Hearn J, Videtic G. Chapter 6: Thoracic Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM. New York, NY, Demos Medical p. 85-100. 2015.
  3. Jung EW, Tendulkar RD, Stephans KL. Chapter 8: Genitourinary Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM. New York, NY, Demos Medical p. 121-148. 2015.
  4. Jung E, Suh JH, Chao ST, Vogelbaum MA, Barnett GH, Regine WF. Chapter 15: Brain Metastases. In: Chin LC, Regine WF eds. Principles & Practice of Stereotactic Radiosurgery, 2nd edition. New York, NY, Springer Publishing. P. 211-233, 2015.
  5. Kittel J, Macklis R. Chapter 10: Lymphoma and Myeloma Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM. New York, NY, Demos Medical p. 163-188. 2015.
  6. Kotecha R, Chao S, Murphy E, Suh J. Chapter 28: Benign Intracranial Disease: Benign Tumors of the Central Nervous System, Arteriovenous Malformations, and Trigeminal Neuralgia. Target Volume Delineation and Field Setup: A Practical Guide for Conformal and Intensity-Modulated Radiation Therapy. Editors: Lu J, Diaz N, Lee N. Springer; 2015 edition.
  7. Kotecha R, Cherian S. Chapter 9: Gynecologic Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM. New York, NY, Demos Medical p. 149-162. 2015.
  8. Kumar A, Greskovich J, Koyfman S. Chapter 4: Head and Neck Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM. New York, NY, Demos Medical p. 43-66. 2015.
  9. Marwaha G, Vassil A, Videtic G. Chapter 13: Palliative Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM. New York, NY, Demos Medical p. 221-238. 2015.
  10. Merchant TE, Murphy ES. Radiotherapy of pediatric brain tumors. Principals and Practice of Pediatric Neurosurgery. Jan 2014.
  11. Murphy ES, Merchant TE. Pediatric Disorders: Viewpoint- Fractionated Radiotherapy. Principles and Practice of Stereotactic Radiosurgery, 2nd Edition. Chin LS, Regine WF, editors. New York, NY, Springer Publishing. P.427-438, 2015.
  12. Murphy ES, Merchant TE. Teletherapy for Retinoblastoma: Indications, Risk and New Delivery Options. Clinical Ophthalmic Oncology, 2nd edition. Retinoblastoma. Arun Singh, editor. 3/2014.
  13. Murphy ES, Merchant TE. Radiotherapy for pediatric CNS malignancies. The International Society of Pediatric Neurosurgeons Guide to Pediatric Neurosurgery. Online publication July 2014.
  14. Oh S, Tendulkar R. Chapter 5: Breast Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM. New York, NY, Demos Medical p. 67-84. 2015.
  15. Okoye C, Patel R, Lo S, Mansur D, Hdeib A, Sahgal A. Chang E, Machtay M, Suh J, Sloan A. Stereotactic Radiosurgery for Pediatric Brain Tumors. Intracranial radiosurgery, 2nd edition. Lunsford D, Sheehan J, eds. Thieme Medical Publishing 2014
  16. Rizzo AE and Yu JS*. Radiation Therapy for Glioma Stem Cells, In: Ehtesham M, editor. Stem Cell Biology in Neoplasms of the Central Nervous System. New York: Springer, 2014.
  17. Schroeder J, Suh J, Vogelbaum M, Barnett G. Gliomas. Intracranial Stereotactic Radiosurgery, 2nd edition. Eds. Lunsford LD, Sheehan JP. New York, NY. Thieme Publishers
  18. Shukla M, Stephans KL, Wahab M. Chapter 7: Gastrointestinal (non-esophageal) Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM. New York, NY, Demos Medical p. 101-120. 2015.
  19. Stockham A, Suh J, Chao S. Chapter 3: Central Nervous System Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM. New York, NY, Demos Medical p. 27-42. 2015.
  20. Stephans KL, Woody NM, Kotecha R, Videtic GMM. Ch. 33 Treatment planning in thoracic oncology. Treatment planning in radiation oncology, 4th edition. Khan FM, editor. Being prepared.
  21. Suh JH, Chao ST, Murphy ES, Weil RJ. Pituitary tumors and craniopharyngiomas. Clinical Radiation Oncology, 4th edition. Eds. Gunderson L, Tepper J. Churchhill Livingstone. Submitted Dec 2013
  22. Suh JH, Chao ST, Peereboom DP, Barnett GH. Metastatic cancer to brain. In Devita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology, 10th edition. Eds. DeVita V, Lawrence T, Rosenberg S. Philadelphia, Wolters Kluwer. P. 1832-1844. 2015.
  23. Vassil A, Pavelecky N, Magnelli A, Videtic G. Chapter 1: General Physics Principles. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM. New York, NY, Demos Medical p. 1-16, 2015.
  24. Weller M, Murphy E. Chapter 12: Pediatric Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM. New York, NY, Demos Medical. P 201-220. 2015.
  25. Woody NM, Murphy ES, Stephans KL, Amarnath SA. Chapter 9: Sarcoma Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM. New York, NY, Demos Medical. P. 189-200. 2015.
  26. Woody N, Videtic G. Chapter 2: Tools for Simulation and Treatment. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM. New York, NY, Demos Medical. p. 17-26. 2015.
  27. Yu JS, Brown M, Suh JH, Ma L, Sahgal A. Radiobiology of Radiotherapy and Radiosurgery. In Winn HR, editor. Youmans Neurological Surgery. 7th ed. Philadelphia: Elsevier Submitted 2014
ACCEPTED FOR PUBLICATION:
  1. Al-Khudari S, Guo S, Chen Y, Nwizu T, Greskovich JF, Lorenz R, Burkey BB, Adelstein DJ, Koyfman SA. Solitary dural metastasis at presentation in a patient with untreated human papillomavirus associated squamous cell carcinoma of the oropharynx. Head Neck. 2013 Dec 24. E-pub ahead of print
  2. Babcook MA, Sramkoski RM, Fujioka H, Daneshgari F, Almasan A, Shukla S, Nanavaty RR, Gupta S. Combination of simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells. Cell Death & Disease (accepted).
  3. Chang B, Kumar A, Koyfman S, Abdel-Wahab M: Radiation therapy in patients with inflammatory bowel disease and colorectal cancer: risks and benefits. Int J Hepatobil Disease. Int J Colorectal Dis. 2015 Jan 8. [Epub ahead of print]
  4. Cherian S, Kittel J, Reddy CA, Kolar M, Ulchaker J, Angermeier K, Stephans KL, Tendulkar RD, Klein E, Ciezki JP. Safety and Efficacy of I125 Permanent Prostate Brachytherapy in Patients with J-Pouch Anastomosis after Total Colectomy for Ulcerative Colitis. Accepted to PRO Oct 2014.
  5. Choudhary G, Alharbi S, Almasan A. Caspase-3 activation as a critical determinant of genotoxic stress-induced apoptosis. Methods Mol Biol, 1219:1-9, 2015. PMID: 25308257
  6. Choudhary GS, Al-Harbi S, Mazumder S, Hill BT, Smith MR, Bodo J, Hsi ED, Almasan A. MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/ mTORC activation in lymphoid malignancies. Cell Death & Disease (accepted).
  7. Fredman ET, Kumar AMS, Abdel-Wahab M. Ten-Year Comparison of 165 Patients treated with IMRT and 3D Conventional Radiation Therapy for Anal Cancer. Gastrointest Cancer Res 2014. (Accepted)
  8. Ha D, Choi H; Zell K, Raymond DP, Stephans K, Wang XF, Videtic G, McCarthy K, Minai OA, Mazzone PJ. Association of Impaired Heart Rate Recovery with Cardiopulmonary Complications after Lung Cancer Resection Surgery. Journal of Thoracic and Cardiovascular Surgery. In Press.
  9. Hong T, Bosch W, Krishnan S, Kim T, Mamon H, Shyn P, Benjosef E, Seong J, Haddock M, Cheng J, Feng M, Stephans K, Roberge D, Crane C, Dawson L. Interoberserver variability in target definition for hepatocellular carcinoma (HCC) with and without portal vein thrombus: Radiation Therapy Oncology Group (RTOG) consensus guidelines. Int J Radiat Oncol Biol Phys 2014
  10. Hong CW, Reddy CA, Wilkinson DA, Klein EA, Ciezki JP. Influence of zonal dosimetry on prostate brachytherapy outcomes. Accepted to J Contemp Brachytherapy Dec 2014.
  11. Hunter G, Balagamwala E, Koyfman S, et al. The Efficacy of External Beam Radiotherapy and Stereotactic Body Radiotherapy (SBRT) for Painful Spinal Metastases from Renal Cell Carcinoma. Pract Rad Oncol. 2013 (Accepted)
  12. Klionsky DJ, …Almasan A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy, 2015 (in press).
  13. Kotecha R, Zimmerman A, Murphy ES, Ahmed Z, Ahluwalia MS, Suh JH, Reddy CA, Angelov L, Vogelbaum MA, Barnett GH, Chao ST, Management of brain metastasis in patients with pulmonary neuroendocrine carcinomas. Am J Clin Oncol July 2014.
  14. Kotecha R, Berriochoa CA, Murphy ES, Machado AG, Chao ST, Suh JH, Stephans KL. Whole-Brain Radiation Therapy in Patients with Deep Brain Stimulation Implants: Important Neurosurgical Considerations and Radiotherapy Practice Principles. Accepted to J Neurosurg Jan 2014 pending revisions.
  15. Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG, Bendszus M, Brown PD, Camidge Dr, Chang SM, Dancey J, de Vries EGE, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wen PY. Proposed Response Assessment Criteria for Brain Metastases: Response Assessment in Neuro-Oncology (RANO) Working Group. Accepted to Lancet Oncol Jan 2015.
  16. Mahmoud OM, Koyfman SA. Re-irradiation for Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck. J Radiation Oncology.
  17. Mallick S, Gandhi AK, Joshi NP, Pandit S, Bhasker S, Sharma A, Mohanti B. Re-irradiation in head and neck cancers: an Indian tertiary cancer centre experience. Accepted J Laryngol Otology 2014
  18. Man J, Shoemake J, Ma T, Rizzo A, Godley A, Wu Q, Mohammad A, Bao S, Rich J, Yu J. Hyperthermia Sensitizes Glioma Stem Cells to Radiation Through Inhibition of AKT Signaling. Accepted Cancer Research
  19. Murphy E, Xie H, Merchant TE, Yu J, Chao ST, Suh JH. Review of cranial radiotherapy-induced vasculopathy. J Neuro-oncol Feb 2015.
  20. Rath GK, Sharma DN, Mallick S, Gandhi AK, Joshi NP, Haresh KP, Gupta S, Julka PK. Clinical outcome of patients with primary gliosarcoma treated with concomitant and adjuvant temozolomide: A single institutional analysis of 27 cases. Accepted Indian Journal Cancer
  21. Robinson CG, Stephans KL. Neoadjuvant chemoradiotherapy for stage III (N2/3) non-small cell lung cancer – a review of prospective studies. Lung Cancer Management 2013, (Accepted)
  22. Rosko A, McColl, Zhong F., Chang MJ, Sattar A, Hill BT, Alharbi S, Almasan A, Distelhorst C. Acidosis sensing receptor GPR65 correlates with anti-apoptotic Bcl-2 family member expression in CLL cells: Potential implications for the CLL microenvironment. J Leukemia 2015 (in press)
  23. Shukla M, Yu C, Reddy C, Stephans K, Abdel-Wahab M, Ciezki J, Tendulkar R. Evaluation of the Current Prostate Cancer Staging System Based on Cancer- Specific Mortalilty in the Surveillance, Epidemiology, and End Results Database. Accepted to Clinical Genitourinary Cancer 13(1):17-21, 2015.
  24. Stephans K, Djemil T, Diaconu C, Reddy C, Xia P, Woody N, Greskovich J, Makkar V, Videtic G. Esophageal dose tolerance to hypofractionated stereotactic body radiotherapy: Risk factors for late toxicity. Int J Radiat Oncol Biol Phys, in press (2014).
  25. Stockham AL, Koyfman SA, Burdick EA, Reddy CA, Suh JH, Vogelbaum MA, Barnett GH, Chao ST. Validation of the ‘Lesion Quotient’ as a Radiographic Tool to Distinguish between Radiation Necrosis and Tumor Progression for Brain Metastases Treated with Stereotactic Radiosurgery J Neuro-oncol (in press)
  26. Swegal W, Scharpf J, Sindwani R, Greskovich JF, Borden E, Koyfman SA, Burkey BB. Endoscopic and Open Surgical Approaches to Locally Advanced Sinonasal Melanoma: Comparing the Therapeutic Benefits. JAMA Otolaryngol Head Neck Surg 2014 (In Press)
  27. Wang Y, Vassil A, Tendulkar R, Bayouth J, Xia P. Application of Non-flat X-ray Photons to Whole Breast Irradiation Using Direct Aperture Optimization. JCAMP.
  28. Weil RJ, Mavinkurve GG, Chao ST, Kolar M, Vogelbaum MA, Suh JH, Toms SA. Intra-Operative Radiotherapy to Treat Newly-Diagnosed Solitary Brain Metastasis: Initial Experience and Long-term Outcomes. J Neurosurg 2015
  29. Woody NM, Stephans KL, Marwaha G, Djemil T, Videtic GMM. Stereotactic body radiation therapy for non-small cell lung cancer greater than 5 cm: Safety and Efficacy. Int J Radiat Oncol Biol Phys (in press)
  30. Zimmerman AL, Murphy ES, Suh JH, Vogelbaum MA, Barnett GH, Angelov L, Ahluwalia M, Reddy CA, Chao ST. Treatment of large brain metastases with stereotactic radiosurgery. Tech Cancer Res Treat Jan 2015 [Epub ahead of print]
SUBMITTED/BEING PREPARED FOR PUBLICATION:
  1. Amoush A, Abdel-Wahab M, Abazeed M, Xia P. Potential Systematic Errors in IGRT When Different Reference Images are Used for Pancreatic Tumors. Submitted to J App Clin Med Phys (2nd revision) Aug 2014
  2. Amoush A, Long H, Subedi L, Qi P, Djemil T, Xia P: Dosimetric Effect of Multileaf Collimator Leaf Width on Volumetric Modulated Arc Stereotactic Radiotherapy for Spine Tumors, under preparation
  3. Amoush A, Murray E, Yu J, Xia P. Single-isocenter hybrid IMRT plans versus two-isocenter conventional plans and impact of intra-fraction motion for the treatment of breast cancer. J Appl Clin Med Phys (2nd revision) Aug 2014
  4. Berriochoa CA, Videtic GMM, Djemil T, Woody NM, Stephans KL. Lung SBRT for T3N0 tumors with chest wall invasion: Safe and Effective. To be submitted.
  5. Berriochoa CA, Kumar AMS, Khorana AA, Walsh RM, Abdel-Wahab M. Preoperative chemoradiation for locally advanced pancreatic cancer improves margin negativity and nodal involvement at resection. To be submitted.
  6. Buckner JC, Pugh SL, Shaw EG, Gilbert MP, Barger G, Coons S, Ricci P, Bullard D, Brown PD, Stelzer K, Brachman D, Suh JH, Schultz CJ, Bahary J-P, Fisher BJ, Kim H, Murtha AD, Curran WJ Jr., Mehta MP. Long term results of R9802: A Phase III study of radiation therapy (RT) with or without procarbazine, CCNU, and vincristine (PCV) in low-grade glioma. RTOG with Alliance, ECOG-ACRIN and SWOG. Submitted to N Engl Med Nov 2014.
  7. Burkey BB, Han JH, Noble A, Scharpf J, Lamarre E, Khan M, Lorenz RR, Greskovich JF, Koyfman SA. A study of surgically treated early stage tongue cancer: What can we learn about the role of neck dissection and the implications of an intraoperative positive margin? JAMA Otolaryngol Head Neck Surg 2014 (Under revision)
  8. Cherian S, Amarnath S, Juliano J. Justin, Saffle P, Rose P, Michener C, Knight J, DeBernardo R, Fleming P. High dose rate interstitial brachytherapy for locally recurrent gynecological tumors, a single institution experience. (In preparation).
  9. Diaconu C, Stephans KL, Djemil T, Videtic GMM, Abdel-Wahab M, Yu N, Greskovich, Jr, J, Xia P. Intra- and Inter-Fraction Reproducibility of Liver and Lung Tumor Localization for Patients Imaged under Active Breathing Control. Med Phys Dec 2013. (revision)
  10. Drzymala R, Alvarez P, Bednarz G, Bourland D, DeWerdL, Ma L, Meltsner S, Neyman G, Novotny J, Petti P, Rivard M, Shiu A, Goetsch S. A Round Robin Gamma Stereotactic Radiosurgery Dosimetry Intercomparison of Calibration Protocols. Submitted to Medical Physics Journal 2014
  11. Fredman ET, Kumar AMS, Coppa C, El-Gazzaz G, Aucejo FN, Abdel-Wahab M. Local Failure after Liver Resection for Hepatocellular Carcinoma. (Submitted to Chinese HBP)
  12. Gladson C, Ahluwalia M, Weil R, Bae E, Huang P, McGraw M, Grove L, Olman M, Kar N, Prayson R, Suh J, Barnett G. Correlation of Higher Levels of Soluble TNF-R2 in Plasma with a Shorter Survival Time in Patients with Recurrent Glioblastoma Tumors - A Pilot Study. J Neurosurg (Submitted)
  13. Glass J, Won M, Schultz CJ, Brat D, Bartlett N, Suh JH, Fisher BJ, Liepmann MK, Mehta MP. RTOG 0227: Phase I/II Study of Pre-Irradiation Chemotherapy with Methotrexate, Rituximab, and Temozolomide and Post-Irradiation Temozolomide for Primary Central Nervous System Lymphoma. Submitted to J Clin Oncol Mar 2015.
  14. Harel R, Emch T, Chao S, Elson P, Krishnaney A, Djemil T, Suh J, Angelov L. Evaluating local control following Surgery and Spinal Radiosurgery (SRS) for Spine Tumors. Submitted to Journal of Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy April 2013.(Submitted)
  15. Hearn JWD, AbuAli G, Magi-Galluzzi C, Reddy CA, Chang K-H, Klein EA, Sharifi N. HSD3B1 and Resistance to Androgen Deprivation Therapy in Prostate Cancer. To be submitted.
  16. Koyfman S, Joshi N, Vidimos A. Adjuvant radiotherapy in high risk cutaneous squamous cellcncer of the head and neck in immunosuppressed patients. JAAD case report. Submitted Oct 2014.
  17. Joshi N, Rasmussen P, Bain M, Masaryk T, Neyman G, Murphy ES, Chao ST, Suh JH. Large volume cranial arteriovenous malformations: a review. Being prepared.
  18. Joshi N, Rasmussen P, Bain M, Masaryk T, Neyman G, Kotecha R, Murphy ES, Suh JH, Chao ST. Large volume cranial arteriovenous malformations: institutional results with volume staged stereotactic radiosurgery. To be submitted.
  19. Jung EW, Jung DL, Balagamwala EH, Angelov L, Suh JH, Djemil T, Magnelli A, Chao ST. Single fraction spine stereotactic body radiotherapy for treatment of chordoma. (In-process).
  20. Li W, Vassil A, Godley A, Muhieddine LM, Shang Q, Xia P: Using Daily Diagnostic Quality Images with Online and Offline Shifts to Access Planning Margins for Prostate Cancer. Submitted to Med Phys.
  21. Liu H, Zhuang T, Stephans K, Videtic G, Djemil T, Xia P. Dose Differences in Intensity Modulated Radiotherapy Plans Calculated With Pencil Beam and Monte Carlo for Non-small Cell Lung Cancer. Submitted to JACAMP
  22. Lukovic J, Bourque JM, Abdel-Wahab M. Recurrent rectal cancer: time to re-think re-irradiation? J Radiat Oncol submitted 2014
  23. Kittel JA, Reddy CA, Smith KL, Stephans KL, Tendulkar RD, Ulchaker J, Angermeier K, Campbell S, Stephenson A, Klein EA, Wilkinson DA, Ciezki JP. Long-Term Efficacy and Toxicity of Low Dose Rate 125I Prostate Brachytherapy as Monotherapy in Low, Intermediate, and High-Risk Prostate Cancer. To be submitted.
  24. Kotecha R, Zimmerman A, Murphy ES, Ahmed Z, Ahluwalia MS, Suh JH, Reddy CA, Angelov L, Vogelbaum MA, Barnett GH, Chao ST. Management of brain metastasis in patients with neuroendocrine carcinomas of the lung. Submitted to Tech Ca Res Treat Nov 2014
  25. Koyfman SA, Reddy CA, Hizlan S, Leek AC, Kodish E, on behalf of the Phase I Informed Consent (POIC) Research Team. Informed Consent Conversations and Documents: A Quantitative Comparison. Annals of Internal Medicine. 2014 (Submitted).
  26. Koyfman SA, Cooper JS, Yom SS, Beitler JJ, Busse PM, McDonald MW, Quon H, Ridge JA, Saba NF, Salama JK, Siddiqui F, Smith RV, Worden F, Yao M. American College of Radiology Appropriateness Criteria.: Aggressive Non-melanomatous Skin Cancer of the Head and Neck. (In Preparation)
  27. Koyfman SA, Balagamwala EH, Bledsoe TB, Barnett J, Reddy CA, Nwizu T, Chute D, Saxton JP, Burkey BB, Greskovich JF, Adelstein DJ. Intensity Modulated Radiotherapy Reduces Late Toxicity in Patients with Human Papillomavirus-Associated Oropharyngeal Carcinoma Treated with Chemoradiotherapy. (In-process).
  28. Kumar A, Fredman E, Coppa C, El-Gazzaz G, Aucejo F, Abdel-Wahab. Patterns of failure in localized resected hepatocellular carcinoma- patients with close surgical margins may benefit from adjuvant radiotherapy. J Rad Oncol (Submitted)
  29. Li W, Vassil A, Godley A, Muhieddine Mossolly L, Shang Q, Xia P. Using Daily Diagnostic Quality Images with Online and Offline Shifts to Assess Planning Margins for Prostate Cancer. (To be submitted)
  30. Liu H, Zhuang T, Stephans K, Videtic G, Djemil T, Xia P: Dose Differences in Intensity Modulated Radiotherapy Plans Calculated With Pencil Beam and Monte Carlo for Non-small Cell Lung Cancer, To be re-submitted to Technol Cancer Res Treat, due on 10/2014
  31. Magnelli A, Liu H, Zhong Y, Xia P. Experimental and Clinical Evaluation of a CT Image Reconstruction Algorithm for Metal Artifact Reduction. Submitted to J Applied Clinical Med Phys. (Under revision)
  32. Man J, Shoemake J, Godley A, Ma T, Rizzo A, Wu Q, Rich J, Yu JS. Hyperthermia Overcomes the Radioresistance of Glioblastoma Initiating Cells by Downregulation of AKT Signaling. Cancer Research.
  33. Manyam B, Gastman B, Zhang AY, Reddy CA, Burkey BB, Scharpf J, Alam DS, Fritz MA, Vidimos AT, Koyfman SA. Inferior Outcomes in Immunosuppressed Patients with High Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated with Multimodality Therapy. Journal American Academy Dermatology: 2014 (Submitted)
  34. Manyam B, Mallick I, Abdel-Wahab MM, Reddy CA, Pelley RJ, Remzi FH, Kalady MF, Lavery I, Kiran RP, Koyfman SA. The Impact of Preoperative Radiation Therapy on Locoregional Recurrence in Patients with Stage IV Rectal Cancer Treated with Definitive Surgical Resection and Contemporary Chemotherapy. Journal of Gastrointestinal Surgery. 2014 (Submitted)
  35. Marwaha G, Medina C, Naik M, Ward MC, Wilkinson A, Singh AD. Ruthenium Eye Plaques for Uveal Melanoma: Long-term clinical outcomes. To be submitted to JAMA Opthalmology
  36. Mohammadi AM, Weil RJ, Marko NF, Chao ST, Barnett GH, Vogelbaum MA, Suh JH, Neyman G, Angelov L. Prognostic factors associated with progression free survival and volumetric tumors response after stereotactic radiosurgery in patients with ≥5 brain metastases. Submitted to World Neurosurg Aug 2013. (rejected)
  37. Naik M, Reddy CA, Stephans KL, Tendulkar RD. Post-Treatment PSA 6 months after Radiation and Androgen Deprivation Therapy Predicts for Distant Metastases and Prostate Cancer Specific Mortality. In Preparation
  38. Naik M, Ward M, Rodriguez CP, Kumar AMS, Rybicki LA, Saxton JP, Scharpf J, Burkey B, Hoschar AP, Greskovich JF, Adelstein DJ, Koyfman SA. HPV Positive Oropharynx Patients have Reduced Toxicity Independent of IMRT. In Preparation
  39. Naik M, Marta NG, Abdel-Wahab M. Re-irradiation of Locally Recurrent Prostate Cancer After Primary Radiotherapy. Submitted to Journal of Radiation Oncology
  40. Noble A, Han JH, Greskovich JH, Nwizu TH, Adelstein DJ, Reddy CA, Khan CA, Scharpf J, Burkey BB, Koyfman SA. Patterns of Failure and Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative (Chemo)Radiotherapy. Head Neck. 2014 (Submitted)
  41. Moulton L, Nutter B, Cherian S, Rose PG. Does radiation therapy improve survival in patients with uterine clear cell carcinoma undergoing adjuvant chemotherapy? Submitted to Gyn Oncol
  42. Pham YD, Kittel JA, Reddy CA, Ciezki JP, Klein EA, Stephans KL, Tendulkar RD. Improved Biochemical Control after Permanent Prostate Seed Implantation for Large Prostate Glands > 60 Grams Compared to Smaller Glands. To be submitted
  43. Qu H, Yu N, Stephans K, Xia P: The Effect of Different Regional Lung Volume Definitions and Breathing Patterns on Lung Ventilation Calculation, submitted to Med. Phys. 9/2014
  44. Russo S, Blackstock AW, Herman J, Abdel-Wahab M, Azad N, Goodman K,. Hong T, Jabbour S, Jones W, Konski A, Koong A, Kumar R, Rodriguez-Bigas M, Small W, Thomas C, Suh W: ACR Appropriateness Criteria Local Excision in Early Stage Rectal Cancer CGR (submitted 2014).
  45. Shang Q, Huang L, Qi P, Xia P. Sensitivity of Gamma Index as a Patient Specific IMRT QA Metric in Detection of MLC Leaf Positioning Errors using MatriXX 2D Array. Submitted to Med. Phys. Sept 2013 (Under revision)
  46. Shen Z, Xia P, Klahr P, Djemil T. Dosimetric Impact of Orthopedic Metal Artifact Reduction (O-MAR) on Spine SBRT Patients. Submitted to Journal of Clinical Applied Medical Physics (2nd revision) 9/2014
  47. Song A, Chao. Adult medulloblastoma. Being prepared.
  48. Tariq MB, Balagamwala EH, Chao ST. Re-irradiation in central nervous system tumors. J Radiat Oncol. Submitted Aug 2014
  49. Tariq M, Meier T, Suh JH, Reddy C, Godley A, Hugebeck B, Kolar M, Barrett P, Chao ST. Workload may contribute to errors in radiation oncology. Submitted to Pract Radiat Oncol March 2015.
  50. Thibault I, Atenafu EG, Chang E, Chao ST, Al-Omair A, Zhou S, Boehling N, Balagamwala EH, Cunha M, Cho J, Angelov L, Brown PD, Suh JH, Rhines LD, Fehlings MG, Sahgal A. Risk of Vertebral Compression Fracture Specific to Osteolytic Renal Cell Carcinoma Spinal Metastases after Stereotactic Body Radiotherapy: A Multi-Institutional Study. Submitted to Spine July 2014.
  51. Videtic GMM, Hu C, Singh AK, Chang JY, Parker W, Olivier KR, Schild SE, Komaki R, Urbanic JJ, Choy H. RTOG 0915 (NCCTG N0927): A Randomized Phase II Study Comparing 2 Stereotactic Body Radiation Therapy (SBRT) Schedules for Medically Inoperable Patients with Stage I Peripheral Non-Small Cell Lung Cancer. (Submitted)
  52. Vogelbaum MA, Hu C, Peereboom DM, Macdonald DR, Giannini C, Suh JH, Jenkins RB, Laack NN, Brachman DG, Shrieve DC, Souhami L, Mehta MP. Phase II Trial of Pre-Irradiation and Concurrent Temozolomide in Patients with Newly Diagnosed Anaplastic Oligodendrogliomas and Mixed Anaplastic Oligoastrocytomas: Long Term Results of RTOG BR0131. Submitted Aug 2014 to Neuro-oncol.
  53. Ward M, Pham Y, Kotecha R, Zakem S, Greskovich J. Clinical and dosimetric implications of intensity modulated radiotherapy for early stage glottic carcinoma. Submitted to .
  54. Weller M, Tendulkar RD, Reddy CA, Stephans KL, Kupelian PA. Adjuvant vs Neoadjuvant Androgen Deprivation with Radiation Therapy for Prostate Cancer: Does Sequencing Matter? Submitted to Clinical Genitourinary Cancer Oct 2014.
  55. Weller MA, Kupelian P, Reddy C, Kotecha R, Ciezki J, Klein E, Stephans K, Tendulkar R. Hypofractionated Intensity-Modulated Radiotherapy for Localized Prostate Cancer: Long Term Outcomes and a Comparison to Standard Dose-Escalated RT. Submitted Int J Radiat Oncol Biol Phys Oct 2014.
  56. Wilkinson DA, Kolar MD. Quality Assurance for Patient Specific HDR Treatment Plans. (Being prepared)
  57. Wong RKW, Deshmukh S, Wyatt G, Sagar S, Singh AK, Sultanem K, Nguyen-Tân PF, Yom SS, Cardinale J, Yao M, Hodson I, Matthiesen CL, Suh JH, Thakrar H, Pugh SL, Berk L. Acupuncture-like Transcutaneous Electrical Nerve Stimulation versus Pilocarpine in Treating Early Radiation-Induced Xerostomia: Results of RTOG 0537 Phase 3 Study. Submitted to Int J Radiat Oncol Biol Phys Sept 2014.
  58. Woody NM, Stephans KL, Videtic GMM, Djemil T, Xia P. Potential systemic errors in lung stereotactic body radiation therapy (SBRT) planning and delivery. Submitted to J Radiat Oncol.
  59. Woody NM, Koyfman SA, Xia P, Yu N, Shang Q, Adelstein DJ, Scharpf J, Burkey B, Saxton JP, Greskovich Jr. JF. Dose de-escalated radiotherapy to involved lymph nodes in HPV positive oropharyngeal cancer is associated with excellent loco-regional control. Submitted Int J Radiat Oncol Biol Phys (2nd revision).
  60. Woody NM, Bricker A, Zakem S, Greer M, Joshi N, Koyfman SA. Carotid blowout in a patient treated with nasopharyngeal treated with SBRT re-irradiation for local recurrence using twice weekly treatment. To be submitted.
  61. Woody NM, Durand P, Naik M, Coopey SB, Dietz J, Djohan R, Tendulkar RD. Long term outcomes of mastectomy with tissue expander based reconstruction and the effects of radiotherapy and co-morbidities. To be submitted.
  62. Yu N, Qu H, Stephans K, Srinivas S, McLennan G, Xia P. Patient Breathing Effect on Liver Y90 Dosimetry Derived From Post-Embolization Y90 PET, to be submitted to the Int J Radiat Oncol Biol Phys. Submitted Radioth Oncol Nov. 2014.
  63. Zhuang TL, Effect of intrafraction motion in a single fraction step-and-shoot IMRT with ablative dose.
  64. Zimmermann L, Amoush A, Wilkinson D: Episcleral Eye Plaque Dosimetry Comparison for the Eye Physics EP917 Using Plaque Simulator and Monte Carlo Simulation, submitted to Medical Physics
EXTERNAL PRESENTATIONS:

32nd Annual Leland R. Cowden Cancer Symposium: Update on CNS Neoplasms. Salt Lake City, UT. Jan 26, 2014
  1. Suh JH. Approach to treating solitary brain metastases.
2014 Multidisciplinary Head and Neck Cancer Update, Fort Myers, FL (February 2014)
  1. Greskovich J. Is FDG PET-CT Needed for Radiation Therapy Planning? February 14, 2014
  2. Greskovich J. Adjuvant Radiation Therapy for Salivary Gland Tumors February 15, 2014
  3. Koyfman S. Does IMRT Really Reduce Late Effects? February 14, 2014
  4. Koyfman S.RTOG Update from 2014 Spring Meeting February 14, 2014
  5. Xia P. Is Adaptive Radiation Ready for Prime Time? February 15, 2014
2014 ASTRO-ASCO-AHNS (Biennial) Multidisciplinary Head and Neck Cancer Symposium (February 20, 2014)
  1. Greskovich JF, Gordian M, Lorenz R, Scharpf J, Khan M, Burkey BB, Ives D, Nwizu TI, Koyfman SA, Adelstein DJ. Improving Healthcare Value in Patients with Stage III-IVb Squamous Cell Carcinoma of Head and Neck (HNSCC): Comparative Effectiveness of Two Arms of a Randomized, Phase III Trial of Definitive Chemoradiation (ChemoRT). Oral Presentation at Plenary Session.
  2. Swegal W, Scharpf, Sindwani, Greskovich JF, Borden E, Koyfman SA, Burkey BB. Endoscopic and Open Surgical Approaches to Locally Advanced Sinonasal Melanoma: Comparing the Therapeutic Benefits. Poster
  3. Koyfman SA, Noble A, Han JH, Greskovich JH, Nwizu TH, Adelstein DJ, Reddy CA, Khan CA, Scharpf J, Burkey BB. Patterns of Failure and Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity (SCC-OC) Treated with Surgery and Postoperative (Chemo)Radiotherapy. Poster
  4. Koyfman SA, Bledsoe TB, Barnett J, Reddy CA, Nwizu T, Chute D, Saxton JP, Burkey BB, Greskovich JF, Adelstein DJ. Modest Late Toxicity and Excellent Quality of Life in Patients with Human Papillomavirus (HPV+) Associated Oropharyngeal Carcinoma Treated with Intensity Modulated Radiotherapy (IMRT) and Concurrent Chemotherapy. Poster
  5. Manyam B, Saxton JP, Reddy CA, Burkey BB, Scharpf J, Zhang AY, Alam DS, Fritz MA, Vidimos AT, Koyfman SA. Inferior Outcomes in Immunosuppressed Patients with High Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated with Surgery and Radiation Therapy. Poster
  6. Bodman JW, Rybicki LA, Harr BA, Ives DI, Koyfman SA, Nwizu TI, Greskovich JF, Rahe ML, Adelstein DJ. Return to Work and Quality of Life after Chemoradiotherapy for Head and Neck Cancer. Poster.
  7. Harr BH, Bodmann JW, Koyfman SA, Nwizu TI, Greskovich JF, Hamker JJ, Ives DI, Rahe ML, Adelstein DJ. Development of a Head and Neck Cancer Survivorship Clinic: The Cleveland Clinic Experience. Poster
  8. Nwizu TI, Koyfman SA, Bledsoe TB, Hyslop E, Reddy CA, Lamarre E, Scharpf J, Lorenz R, Khan M, Burkey B, Greskovich J, Adelstein DJ. Risk factors predictive for poor outcomes in patients with human papillomavirus (HPV)-initiated oropharyngeal cancer (OPC). Poster
7th Annual SBRT/SRS Symposium, Naples, FL (February 21-23, 2014)
  1. Chao S. Brain SRS- Moderator February 21, 2014
  2. Chao S. Acoustic Neuromas and Hearing Preservation. February 21, 2014
  3. Murphy ES. Pediatric Radiosurgery. February 21, 2014
  4. Ciezki J. Prostate Cancer SBRT vs. Brachytherapy. February 22, 2014
  5. Suh J. Plenary Session I- Moderator. February 22, 2014
  6. Suh J. Radiosurgery Alone vs. Whole Brain Radiation for Multiple Brain Metastases. February 22, 2014
  7. Chao S. Abdomen and Pelvis- Moderator February 23, 2014
  8. Chao S. Radiobiology of Radiosurgery: Response and Radiation Necrosis. February 23, 2014
  9. Stephans K. SBRT for Prostate Cancer. February 23, 2014
  10. Stephans K. Lung SBRT- Moderator February 23, 2014
ACRO meeting Fort Myers, FL (February 26-28, 2014)
  1. Videtic G. SBRT vs. Surgery for Early Stage Lung Cancer. February 27, 2014
Update on Management of Gliomas: What Every Physician Should Know, Independence, OH, invited speaker, March 2014
  1. Yu JS, Reirradiation for Recurrent Gliomas,
  2. Yu JS, Molecular Pathology of Gliomas,
American Radium Society 2014 (May 2014)
  1. Greskovich JG, Kolar MD, Wilkinson A, Godley A. Improving Clinical Outcomes in Definitive Treatment of Esophageal Cancer Using a Novel Endoesophageal 3-tube HDR Technique (poster)
Society for Thermal Medicine Annual Conference, Minneapolis, MN, invited speaker, May 2014
  1. Yu JS, Godley A, Development of the Center For Hyperthermia: The Cleveland Clinic Experience,
  2. Yu JS, Cancer Stem Cells Are Targets for Thermotherapy
ASCO-ASTRO GI symposium
  1. Manyam B, Koyfman S , Sohal D, Mallick I, Remzi F, Kalady M, Lavery I, Kiran P Abdel-Wahab M: Does upfront definitive surgical resection with delayed chemotherapy in patients with stage IV rectal cancer compromise overall survival ? 2014 ASCO-ASTRO GI symposium J Clin Oncol 32, 2014 (suppl 3)
  2. Fredman E, Kumar A, Abdel-Wahab M :Comparing outcomes and toxicities from intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy for anal cancer: Is one really better? 2014 ASCO-ASTRO GI symposium J Clin Oncol 32, 2014 (suppl 3; abstr 589)
  3. Chang B, Kumar A, Kiran R, Kalady M, Lavery I, Abdel-Wahab M: Do inflammatory bowel disease patients experience more toxicity after radiotherapy for colorectal and anal cancer? 2014 ASCO-ASTRO GI symposium J Clin Oncol 32, 2014 (suppl 3)
  4. Kumar A, Falk G, Stephans K, Walsh M, Pelley R, Abdel-Wahab M: influence of adjuvant treatment on outcomes in resectable pancreatic cancer 2014 ASCO-ASTRO GI symposium J Clin Oncol 32, 2014 (suppl 3)
17th International Leksell Gamma Knife Society Meeting in NY (May 11- 15, 2014 )
  1. Goetsch SJ, Neyman G, Drzymala RE, Alvarez PE, Bednarz G, Bourland JD, DeWerd LA, Ma L, Meltsner SG, Novotny J, Jr., Petti PL, Rivard MJ, Shiu AS. Multi-institution evaluation of a new Gamma Knife radiation dosimetry protocol (Oral);
ASCO 56th Annual Meeting, Chicago, IL (May 31-June 4, 2014)
  1. Ahluwalia M, Venur V, Du L, Angelov L, Chao S, Elson P, Mohammadi A, Peereboom D, Budd T, Barnett G, Suh J, Abraham J. New graded prognostic index for breast cancer patients (pts) with brain metastases (BCBM).
  2. Agwa E, Chao S, Du L, Venur V, Elson P, Barnett G, Angelov L, Suh J, Ahluwalia M. Validation study of graded prognostic assessment (GPA) of non-small cell lung cancer (NSCLC) patients with brain metastases (BM).
  3. Buckner J, Pugh S, Shaw E, Gilbert M, Barger G, Coons S, Ricci P, Bullard D, Brown P, Stelzer K, Brachman D, Suh J, Schultz C, Bahary J, Fisher B, Kim H, Murtha A, Curran W, Mehta M. Phase III study of radiation therapy (RT) with or without procarbazine, CCNU and vincristine (PCV) in low-grade glioma: RTOG 9802 with Alliance, ECOG and SWOG.
  4. Du L, Chao S, Venur V, Agwa E, Elson P, Suh J, Ahluwalia M. Revised graded prognostic assessment (GPA) index for small cell lung cancer (SCLC) patients 9pts) with brain metastases (BM).
  5. Ilson D, Moughan J, Suntharalingam M, Dicker A, Kachnic L, Konski A, Chakravarthy B, Anker C,Thakrar H, Horiba N, Kavadi V, Deutsch M, Raben A, Roof K, Suh J, Pollock J, Safran H, Crane C. RTOG 0436: A phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer treated without surgery.
  6. Sidana S, Jia X, Gerds A, Hamilton B,Tiu R, Saunthararajah Y, Maciejewski J, Reu F, Carraway H, Hill B, Smith M, Kalaycio M, Suh J, Sekeres M, Mukherjee S. Risk of hematologic malignancies following radiation treatment for well-differentiated thyroid cancer in the United States over 37 year.
  7. Venur V, Sakruti S, Du L, Randhawa J, Agwa E, Murphy E, Yu J, Chao S, Suh J, Elson P, Angelov L, Ahluwalia M. New graded prognostic index (GPI) for melanoma patients with brain metastasis (MBM).
ICE/ENDO Chicago, IL (June 21-24, 2014)
  1. Niwattisaiwong S, Suh JH, Weil RJ, Hamrahian A. Significant hypercortisolism during fractionated radiotherapy in a patient with large corticotroph macroadenoma: A rare side effect of radiotherapy. (Poster)
AAPM 56th Annual Meeting (July 2014)
  1. Amoush A, Subedi L, Long H, Djemil T, Xia P. Dosimetric Effect of Multileaf Collimator Leaf Width on Volumetric Modulated Arc Stereotactic Radiotherapy for Spine Tumors.
  2. Balik S, Weiss E, Dogan N, Fatyga M, Sleeman W,Wu Y, Hugo G: “Impact of Different Patient Setup Strategies in Adaptive Radiation Therapy with Simultaneous Integrated Volume-Adapted Boost of NSCLC. (Oral)
  3. Balik S, Weiss E, Jan N, Zhang L, Roman N, Gary Christensen G, Williamson J, Geoffrey Hugo. Dosimetric Evaluation of DIR Mapped Contours for Image Guided Adaptive Radiotherapy with 4D Cone-Beam CT. (Poster)
  4. Mishra K, Godley A. Deformed planning CT as an electron density substitute for cone-beam CT (Accepted)
  5. Li Z, Shang Q, Liu H, Greskovich J, Koyfman S, Xia P. Is Off-line Adaptive Radiotherapy Sufficient for Head and Neck Cancer with IGRT.
  6. Liu H, Cherian S, Stephans K, Videtic G, Qi P, Xia P, Zhuang T. Under Dose Regions Recalculated by Monte Carlo Cannot Predict the Local Failure for NSCLC Patients Treated with SBRT.
  7. Qi P, Xia P. Robustness of volumetric-modulated arc therapy plan to MLC positional errors
  8. Qu H, Yu N, Stephans K, Xia P. A Normalization Method Can Remove Discrepancy in Ventilation Function Due to Different Breathing Patterns.
  9. Shang Q, Li Z, Liu H, Greskovich J, Koyfman S, Xia P. Quantitative Assessment for Timely Adaptive Re-planning using Weekly Dose Monitoring for Head and Neck Cancer.
  10. Shen Z, Klahr P, Xia P, Djemil T. Evaluation of an Orthopedic Metal Artifact Reduction (O-MAR) Algorithm on Patients with Spinal Prostheses near Spinal Tumors. (Poster)
  11. Shen Z, Bzdusek K, Shang Q, Xia P. Comprehensive Evaluation of Three Deformation Image Registration Algorithms Using Digital Phantoms Created from Patients with Head and Neck Cancer. (Poster)
  12. Wilkinson A, Kolar M. Use of Implant Volume for Quality Assurance of Low Dose Rate Brachytherapy Treatment Plans. (Poster)
  13. Yu N, Qu H, Xia P. Correlation of Mean Lung Ventilation Value with Ratio of Total Lung Volumes.
National Center for Regenerative Medicine Cancer Stem Conference, Cleveland, OH, invited speaker, August 2014
  1. Yu JS, Sema3C Promotes Glioma Stem Cell Survival and Tumorigenesis Through Rac1,
ASTRO 56th Annual Meeting in San Francisco, CA. Sept 14-17, 2014
  1. Abazeed M. Adams D, Tamayo P, Yard B, Loeffler J, Suh J, Wong K. Hammerman P, Meyerson M, Schreiber. The radiogenomic landscape of cancer. (Oral)
  2. Abazeed M, Xu C. Adams D, Leoffler J, Suh J, Meyerson M, Wong K, Hammerman. NRF2 is a novel oncogene and biomarker of therapeutic resistance in non-small cell lung cancer. (Oral)
  3. Ahmed Z, Balagamwala E. Angelov L, Jung D, Suh J, Reddy C, Djemil T, Magnelli A, Soeder S, Chao S. Spine Stereotactic Radiosurgery in the Management of Sarcoma Metastasis.
  4. Amoush A, Abdel- Wahab M, Xia P. Potential Systematic Error in IGRT When Different Reference Images are Used for Pancreatic Tumors. (Poster)
  5. Berk LB, Deshmukh S, Fogh S, Roof K, Yacoub S, Gergel T, Stephans K, Rimner A, DeNittis A, Pablo J, Rineer J, Chakravarti A, Bruner D. RTOG 1012: Randomized Phase II Trial of Best Supportive Care, Manuka Honey Liquid and Manuka Honey Lozenges for Prevention of Radiation Esophagitis During Chemotherapy and Radiotherapy for Lung Cancer. (Oral)
  6. Berriochoa C, Kumar A, Khorana A, Walsh M, Wahab M. Preoperative chemoradiation for locally advanced pancreatic cancer improves margin negativity and nodal involvement at resection. (Poster)
  7. Berriochoa C, Videtic G, Djemil T, Woody N, Stephans K. Lung SBRT for tumors with chest wall involvement: Safe and effective. (Poster)
  8. Berriochoa C, Videtic G, Djemil T, Woody N, Stephans K. Lung SBRT for T3N0 tumors with chest wall invasion: Safe and Effective.
  9. Bhateja P, Ward M, Bledsoe T, Reddy C, Burkey B, Abazeed M, Adelstein D, Nwizu T, Greskovich J, Koyfman S. Definitive Chemoradiation (CRT) for Organ Preservation in Locally Advanced Squamous Cell Carcinoma of the Hypopharynx (SCC-HP): Oncologic Outcomes and Late Toxicity. (Accepted)
  10. Brigotti S, Stephans K, Reddy C, Djemil T, Woody N, Videtic G. The influence of hematological parameters on tumor control and survival in lung SBRT. (Poster)
  11. Chao S, Meier T, Godley A, Hugebeck B, Kolar M Barrett P, Reddy C, Suh J. One Year Experience with the Workflow Enhancement (WE) Team: Does Continuous Improvement Have to be Continuous?
  12. Ciezki J, Chandana C, Wilkinson A, Klein E. Infludence of Zonal Dosimetry on Prostate Bracytherapy Outcomes. (Poster)
  13. Hearn J, Yard B, Adams D, Tamayo P, Schreiber S, Meyerson M, Hammerman P, Abazeed M. Integrative Radiogenomic Profiling Identifies BRAF Mutations as Novel Radiotherapeutic Targets in Adenocarcinomas of the lung. (Oral)
  14. Hong C, Reddy C, Wilkinson A, Klein E, Ciezki J. Influence of Zonal Dosimetry on Prostate Brachytherapy Outcomes.(Poster)
  15. Joshi N, Rasmussen P, Kumar A, Neyman G, Suh J, Bain M, Masaryk T, Chao S. Staged Gamma Knife Radiosurgery for Large Volume Arteriovenous Malformations: A Single Institution Retrospective Review and Initial Results. (Poster)
  16. Kittel J, Lee J, Woody N, Zimmerman A, Murphy E, Barnett G, Vogelbaum M, Steven G, Suh J, Chao S. Adjuvant Radiation May Not be Necessary Following Gross Total Resection of Atypical meningioma. (Poster)
  17. Kotecha R, Marwaha G, Hearn J, Weller MA, Kupelian PA, Reddy CA, Ciezki JP, Stephans KL, Tendulkar RD. A comparison of long-term treatment-related toxicities between moderately hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer. (Poster)
  18. Kotecha R, Zimmerman Z, Ahmed Z Murphy E, Ahluwalia M, Reddy C, Suh J, Angelov L, Vogelbaum M, Barnett G, Chao S. Management of brain metastasis in patients with neuroendocrine carcinomas of the lung. (accepted)
  19. Koyfman, Bledsoe T, Barnett G, Reddy C, Nwizu T, Chute D, Saxton J, Burkey B, Greskovich J, Adelstein. Intensity Modulated Radiotherapy (IMRT) Reduces Late Toxicity Without Increasing Cost in Patients with Human Papillomavirus Associated (HPV+) Oropharyngeal Carcinoma Treated with Chemoradiotherapy (CRT) (Poster)
  20. Kumar A, Juliano J, Walsh M, Chalikonda S, Stephans K. HDR Brachtherapy for Resected Retroperitoneal Sarcoma in the Primary and Recurrent Setting. (Poster)
  21. Marwaha G, Medina C, Naik M, Ward M, Wilkinson A, Singh A. Ruthenium Eye Plaques for Uveal Melanoma: Long-term clinical outcomes. (accepted)
  22. Marwaha G, Naik M, Videtic G, Abdel-Wahab M, Stephans K. Stereotactic Body Radiotherapy (SBRT) for Adrenal Metastases: Excellent outcomes for a (carefully selected) field. (Poster)
  23. Meier T, Suh J, Godley A, Hugebeck B, Barrett P, Kolar M, Chao S. A Rapid Large Increase in Patient Visits Can Compromise Quality and Safety in Radiation Oncology Treatment Delivery (Poster)
  24. Naik M, Reddy CA, Stephans KL, Tendulkar RD. Post-treatment PSA 6 months after radiation and androgen deprivation therapy predicts for distant metastases and prostate cancer specific mortality. (Poster)
  25. Oh SC, Tariq MB, Reddy CA, Ciezki J, Stephans KL, Tendulkar RD. Outcomes in organ transplant patients with prostate cancer treated with radiotherapy. (Poster)
  26. Pham YD, Kittel JA, Reddy CA, Ciezki JP, Stephans KL, Tendulkar RD. Improved biochemical control after permanent prostate seed implantation for large prostate glands >60 grams compared to smaller glands. (Poster)
  27. Shen ZL, Klahr P, Stephans K, Videtic GM, Xia P, Djemil T. Clinical Evaluation of a Novel Exponential Weighting Algorithm for 4DCT Reconstruction. (Poster)
  28. Shukla ME, Ward MC, Stephans KL, Reddy CA, Garcia J, Stephenson AJ, Rini BI, Klein EA, Tendulkar RD. Early salvage pelvic radiotherapy for lymph node positive prostate cancer following prostatectomy. (Poster)
  29. Song A, Kumar A, Murphy E, Tekautz T, Suh J, Recinos V, Chao S. Adult Medulloblastoma: Survival, Recurrence, and Prognostic Factors.
  30. Stephans KL, Woody NM, Reddy CA, Magnelli A, Zhuang T, Djemil T, Videtic GMM. Time will tell: Is 60 Gy in 3 fractions the optimal SBRT schedule for stage I non-small cell lung cancer? (Poster)
  31. Thibault I, Atenafu E, Chang E, Chao S, Al-Omair, Boehling N, Balagamwala E, Cunha M, Angelov L, Brown P, Suh J, Rhines L, Fehlings M, Sahgal A. Factor influencing vertebral compression fracture specific to renal cell carcinoma spinal metastases after stereotactic body radiotherapy: A multi-institutional study. (Oral)
  32. Tseng C, Thibault I, Atenafu E, Chao S, Al-Omair A, Boehling J, Balagamwala E, Cunha M, Angelov L, Brown P, Suh J, Rhines L, Fehlings M, Chang D, Sahgal A. De Novo vs. Progression of the Existing Vertebral Compression Fracture (VCF) Following Spine Stereotactic Body Radiotherapy (SBRT): Separate Risk Profiles to Consider. (Oral)
  33. Videtic G, Reddy C, Woody N, Djemil T, Stephans. 5 years and beyond: Characterizing long term survivors after stereotactic body radiotherapy (SBRT) for early stage lung cancer. (Poster)
  34. Ward M, Bhateja P, Bledsoe T, Reddy C, Adelstein D, Nwizu T, Greskovich J, Burkey B, Xia P, Koyfman S. Nasogastric Enteral Feeding is Superior to Percutaneous Gastrostomy in Preventing Late Pharyngeal Dysfunction in Long-term Survivors of Locoregionally Advanced Head and Neck Squamous Cell Cancer (HNSCC) treated with Definitive Chemoradiotherapy (CRT). (Poster)
  35. Ward M, Bhateja P, Bledsoe T, Reddy C, Adelstein D, Nwizu T, Greskovich J, Burkey B, Xia P, Koyfman S. Reduction of Severe Late Toxicity After Definitive Chemoradiotherapy (CRT) using Intensity Modulated Radiation Therapy (IMRT) in Non-HPV Associated Head and Neck Squamous Cell Cancer (HNSCC): More than Xerostomia. Submitted to the 56th annual meeting of the American Society of Radiation Oncology, September 14-17, 2014, in San Francisco, CA. (Poster)
  36. Ward M, Bhateja P, Bledsoe T, Reddy C, Adelstein D, Nwizu T, Greskovich J, Burkey B, Xia P, Koyfman S. Reduction of Severe Late Toxicity After Definitive Chemoradiotherapy (CRT) using Intensity Modulated Radiation Therapy (IMRT) in Non-HPV Associated Head and Neck Squamous Cell Cancer (HNSCC): More than Xerostomia. (Poster)
  37. Weller M, Reddy C, Fox T, Cherian S, Wilkinson A, Fleming P. High Dose Rate Brachytherapy in the Treatment of Cervical Cancer: a Single Institution Experience.
  38. Weller MA, Reddy CA, Kittel J, Smith K, Tendulkar RD, Stephans KL, Klein EA, Angermeier KW, Ulchaker J, Campbell S, Stephenson A, Ciezki JP. Comparison of outcomes between brachytherapy and intensity modulated radiotherapy in high risk prostate cancer. (Poster)
  39. Woody NM, Durand P, Naik M, Elegbede A, Duraes E, Coopey SB, Dietz J, Djohan R, Tendulkar RD. Impact of breast radiotherapy on late toxicities and reoperation following mastectomy with tissue expander based reconstruction. (Oral)
  40. Yu N, Kolar M, Kuras M, Barrett P, Suh J, Chao S, Young R, Meier T, Xia P. Automatic monitoring of patient chart status improves workflow for external beam radiotherapy. (Poster)
60th Annual Meeting of the Radiation Research Society, Las Vegas NV, 09-24-2014
  1. Almasan A. Symposium 29 “NF-kB signaling network in radiation response”
Northside Cancer Center, Breast Cancer Symposium, Youngstown, OH, invited speaker, October 2014
  1. Yu JS, Hyperthermia and Radiation for Patients with Recurrent Chest Wall Disease,
2014 Penn-Ohio Fall Symposium AAPM Fall Symposium, Cranberry Township, PA, Oct. 17-18,2014
  1. Shen Z, Bzdusek K, Shang Q, Xia P. Comprehensive Evaluation of Three Deformation Image Registration Algorithms Using Digital Phantoms Created from Patients with Head and Neck Cancer.
2014 CSTRO/SANTRO Symposium, Nanjing, China. Oct 23-25, 2014
  1. Xia P. Role of Record and Verify System in Big Data: Automation in Care Flow Monitoring. 10/25/2014
12th Annual Innovation Summit. Cleveland, OH. Oct 26-29, 2014
  1. Greskovich JG. The future of cancer imaging: The next generation software and hardware. Oct 28, 2014.
  2. Suh JH. Radiation therapy: The role of photons, protons, and particles. Oct 29, 2014.
16th Annual Brain Tumor Update and 4th International Symposium on Long-Term Control of Metastases to the Brain. Las Vegas, NV. November 2014.
  1. Suh JH. Conventional radiotherapy for spinal tumors. Nov 7, 2014.
  2. Chao SC. Role of neoadjuvant radiosurgery for brain metastases. Nov 7, 2014.
  3. Chao SC. Radiation necrosis. Nov 8, 2014.
Case Western Reserve University DNA Damage & Repair Focus Group Seminar, 11-11-2014
  1. Almasan A.
19th Annual SNO Meeting. Miami Beach, Fl. November 13-16, 2014
  1. Suh JH. Radiosurgery and fractionated radiation therapy. Educational session (invited). Nov 13, 2014.
  2. Abbassy M, Missios S, Barnett GH, Brewer C, Peereboom D, Ahluwalia M, Neyman G, Chao ST, Suh JH, Vogelbaum MA. Phase I Trial of Dose Escalated Radiosurgery Plus Bevacizumab in Patients with Recurrent/Progressive Glioblastoma. Poster
Markey Cancer Center, University of Kentucky, Lexington, KY, 11-24-2014
  1. Almasan A.
RSNA Meeting 2014. Chicago, IL. (November 28- Dec 1, 2014)
  1. Abdel-Wahab M, C. Reddy, Gorgun E, Kalady M, Stocchi L, Costedio M, Deitz D, Remzi F: The Impact of Radiation Therapy After Resection on Survival in Rectal Melanoma (poster)
  2. Videtic G. BOOST: Lung-oncology and anatomy. Dec 1, 2014
Targit Academy. Cleveland, OH (Dec 2014)
  1. Cherian S. Radiobiological Aspects of IORT.
  2. Tendulkar R.
TASTRO/TARO 4th Annual Meeting, Taipei, Taiwan, invited speaker, December 2014
  1. Yu JS, Controversies in Nodal Irradiation For Patients With Breast Cancer.
  2. Yu JS, Hyperthermia For Recurrent Breast Cancer
RADIATION ONCOLOGY GRAND ROUNDS
NIH STUDY SECTIONS/ADVISORY GROUPS:
  1. Almasan A. NCI Special Emphasis Panel ZCA1 RTRB-8 (O1) S Omnibus SEP-7, 06-13-2014
  2. Almasan A. NCI Special Emphasis Panel ZCA1 SRLB-1, “NCI Omnibus Cancer Biology 03-2014.
GRANTS AWARDED:
  1. Koyfman S. Phase I Dose Escalation Study of Stereotactic Body Radiotherapy (SBRT) for Squamous Cell Carcinoma of the Head and Neck in High Risk Patients Who are Ineligible/Refuse Standard of Care Therapy. EPCRS Grant - $45,360.00
  2. Abazeed M. Precision Therapeutics in Squamous Cell Lung. National Lung Cancer Program. 03/01/2014 - 02/29/2016 - $50,000.
  3. Abazeed M. Integrative Radiogenomics in Squamous Cell Lung Cancer. RSNA Research Seed Grant. 07/01/2014 - 06/30/2015 $50,000.
  4. Abazeed M. Novel Biomarkers of Therapeutic Resistance in Non-Small Cell Lung Cancer. Lung Cancer Research Foundation. 11/01/2014 - 10/31/2015- $50,000
  5. Koyfman S. Precision Therapeutics in Squamous Cell Cancer of the Head and Neck. Scott Hamilton CARES Initiative Grant. 02/01/2014 – 02/01/2015- $100,000
  6. Yu J. Targeting Glioblastoma Initiating Cells with Thermoradiotherapy and AKT Inhibition. NIH KL2 Mentored Career Development Award, ~$600,000 7/1/14-6/30/18
  7. Yu JS. Autocrine and Paracrine Sema3C Signaling Maintains Glioma Initiating Cells Via Rac1Scott Hamilton CARES Award, $100,000 3/1/14-2/28/15
  8. Yu JS. Semaphorin 3C in Glioblastoma Initiating Cell Survival and Invasion. Amy Post Foundation/Cleveland Clinic Research Program Committee Award, $25,000 11/30/13-11/30/14
Pending Research Support
  1. Abazeed M. Precision targeting of therapeutic resistance in non-small cell lung cancer. NIH KL2 Career Development Award. 07/01/2015 – 07/01/2019
  2. Peacock C. Patient-derived xenografts as avatars of human small cell lung cancer disease. Scott Hamilton CARES Initiative Grant. 02/01/2015 – 02/01/2016
GRANTS SUBMITTED:
  1. Yu J (PI). Sema3C/PlexinD1/Rac1 Signaling Regulates Glioma Stem Cell Tumorigenicity. RO-1 submission.
INVESTIGATOR-INITIATED TRIALS
  1. Murphy ES (PI). Neoadjuvant radiosurgery for resectable brain metastases: phase I/II study.
  2. Chao ST (PI). Dose escalation for larger brain metastases: phase I/II study
  3. Stephans K (PI). Phase II trial of prostate SBRT
COURSE DIRECTOR
  1. Greskovich J (Co-director). 2014 Cleveland Clinic Multidisciplinary Head and Neck Cancer Update. Sanibel Harbour Resort and Spa, Fort Myers, Florida, February 2014.
  2. Chao S, Suh J (Co-directors). 7th Annual SBRT/SRS Symposium. Lake Buena Vista, FL. Feb 2014
  3. Neyman G, Suh JH (co-directors). Gamma Knife Radiosurgery Course for the Cleveland Clinic (March 3-7, May 19-23, Aug 18-22, Sept 29-Oct 3 and Dec. 8 – 12, 2014)
  4. Abdel-Wahab M (Co-director). Cleveland Clinic First Annual Multidisciplinary Colorectal Oncology course. April 2014
  5. Suh J (Co-director) AANS/ASTRO radiosurgery course for senior neurosurgery and radiation oncology residents. New York City, NY. Aug 1-3, 2014.
  6. Suh JH. 2014 ASTRO Review. Independence, OH. Nov 2014
PROSPECTIVE STUDIES/REGISTRIES STARTED 2014

    VISITING PROFESSORSHIPS:

      Publications and Presentations 2015

      Academic activities in Radiation Oncology

      PUBLISHED PAPERS/MONOGRAMS:

      1. Asher Berriochoa C, Hibbard D, Morcos M, Bansal A, Comstock B, Oelschlager B, Pellegrini C, Shankaran V, Zeng J, Patel S. Tumor length as a prognostic factor in esophageal cancer management. J Radiat Oncol 4:71-77, 2015
      2. Chang B, Kumar A, Koyfman S, Abdel-Wahab M: Radiation therapy in patients with inflammatory bowel disease and colorectal cancer: risks and benefits. Int J Hepatobil Disease. Int J Colorectal Dis. 2015 Jan 8. [Epub ahead of print]
      3. Cherian S, Kittel J, Reddy CA, Kolar M, Ulchaker J, Angermeier K, Stephans KL, Tendulkar RD, Klein E, Ciezki JP. Safety and Efficacy of I125 Permanent Prostate Brachytherapy in Patients with J-Pouch Anastomosis after Total Colectomy for Ulcerative Colitis. Pract Radiat Oncol 2015 Apr 17. [Epub ahead of print]
      4. Choudhary G, Alharbi S, Almasan A. Caspase-3 activation as a critical determinant of genotoxic stress-induced apoptosis. Methods Mol Biol, 1219:1-9, 2015. PMID: 25308257
      5. Choudhary GS, Al-Harbi S, Mazumder S, Hill BT, Smith MR, Bodo J, Hsi ED, Almasan A. MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/ mTORC activation in lymphoid malignancies. Cell Death & Disease, 2015,6: e1593; PMID: 25590803.
      6. Hong CW, Reddy CA, Wilkinson DA, Klein EA, Ciezki JP. Influence of zonal dosimetry on prostate brachytherapy outcomes. J Contemp Brachytherapy 7:17-22, 2015.
      7. Kotecha R, Suh JH. In reply to Dr. Chamberlain. J Clin Oncol 2015 Apr 20. pii: JCO.2015.60.9305. [Epub ahead of print]
      8. Man J, Shoemake J, Ma T, Rizzo A, Godley A, Wu Q, Mohammad A, Bao S, Rich J, Yu J. Hyperthermia Sensitizes Glioma Stem Cells to Radiation Through Inhibition of AKT Signaling. Cancer Res Feb 20 2015[Epub ahead of print]
      9. O’Sullivan B, Adelstein DL, Huang SH, Koyfman SA, Thorstad W, Hope AJ, Lewis Jr JS, Nussenbaum B. First site of failure analysis incompletely addresses issues of late and unexpected metastases in p-16 oropharyngeal cancer. J Clin Oncol 2015.
      10. Shukla M, Yu C, Reddy C, Stephans K, Abdel-Wahab M, Ciezki J, Tendulkar R. Evaluation of the Current Prostate Cancer Staging System Based on Cancer- Specific Mortalilty in the Surveillance, Epidemiology, and End Results Database. Accepted to Clinical Genitourinary Cancer 13(1):17-21, 2015.
      11. Weil RJ, Mavinkurve GG, Chao ST, Kolar M, Vogelbaum MA, Suh JH, Toms SA. Intra-Operative Radiotherapy to Treat Newly-Diagnosed Solitary Brain Metastasis: Initial Experience and Long-term Outcomes. J Neurosurg 122:825-832, 2015
      12. Weller MA, Tendulkar RD, Reddy CA, Stephans KL, Kupelian PA. Adjuvant vs Neoadjuvant Androgen Deprivation with Radiation Therapy for Prostate Cancer: Does Sequencing Matter? Published (epub ahead of print 12/31/14) PMID: 25660127
      13. Woody NM, Stephans KL, Videtic GMM, Djemil T, Xia P. Potential systemic errors in lung stereotactic body radiation therapy (SBRT) planning and delivery.   J Radiat Oncol 2015 Apr 1. pii: S0360-3016(15)00151-0 .

      PUBLISHED BOOK CHAPTERS:

      1. Chao ST, Suh JH. Up to 10 Gy. In Controversies in Radiosurgery. Eds. Gerszten P, Sheehan J. Thieme. 152-7. 2014.
      2. Hearn J, Videtic G. Chapter 6: Thoracic Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM. New York, NY, Demos Medical p. 85-100. 2015.
      3. Jung EW, Tendulkar RD, Stephans KL. Chapter 8: Genitourinary Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM. New York, NY, Demos Medical p. 121-148. 2015.
      4. Jung E, Suh JH, Chao ST, Vogelbaum MA, Barnett GH, Regine WF. Chapter 15: Brain Metastases. In: Chin LC, Regine WF eds. Principles & Practice of Stereotactic Radiosurgery, 2nd edition. New York, NY, Springer Publishing. P. 211-233, 2015.
      5. Kittel J, Macklis R. Chapter 10: Lymphoma and Myeloma Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM. New York, NY, Demos Medical p. 163-188. 2015.      
      6. Kotecha R, Chao S, Murphy E, Suh J. Chapter 28: Benign Intracranial Disease: Benign Tumors of the Central Nervous System, Arteriovenous Malformations, and Trigeminal Neuralgia. Target Volume Delineation and Field Setup: A Practical Guide for Conformal and Intensity-Modulated Radiation Therapy. Editors: Lu J, Diaz N, Lee N. Springer; 2015 edition.
      7. Kotecha R, Cherian S. Chapter 9: Gynecologic Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM. New York, NY, Demos Medical p. 149-162. 2015.
      8. Kumar A, Greskovich J, Koyfman S. Chapter 4: Head and Neck Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM. New York, NY, Demos Medical p. 43-66. 2015.
      9. Marwaha G, Vassil A, Videtic G. Chapter 13: Palliative Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition.       Eds Videtic GMM, Woody NM.       New York, NY, Demos Medical p. 221-238. 2015.      
      10. Merchant TE, Murphy ES. Teletherapy for Retinoblastoma: Indications, Risk and New Delivery Options. Clinical Ophthalmic Oncology, 2nd edition. Retinoblastoma. Singh AD, Murphree AL, Damto BE, editors.       Heideilberg, Springer. P. 147-158. 
      11. Murphy ES, Merchant TE. Pediatric Disorders: Viewpoint- Fractionated Radiotherapy. Principles and Practice of Stereotactic Radiosurgery, 2nd Edition. Chin LS, Regine WF, editors. New York, NY, Springer Publishing. P. 427-438, 2015.
      12. Oh S, Tendulkar R. Chapter 5: Breast Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM. New York, NY, Demos Medical p. 67-84. 2015.
      13. Shukla M, Stephans KL, Wahab M. Chapter 7: Gastrointestinal (non-esophageal) Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM. New York, NY, Demos Medical p. 101-120. 2015.
      14. Stockham A, Suh J, Chao S. Chapter 3: Central Nervous System Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM. New York, NY, Demos Medical p. 27-42. 2015.
      15. Suh JH, Chao ST, Peereboom DP, Barnett GH. Metastatic cancer to brain. In Devita, Hellman, and Rosenberg’s Cancer:       Principles and Practice of Oncology, 10th edition. Eds. DeVita V, Lawrence T, Rosenberg S.       Philadelphia, Wolters Kluwer.       P. 1832-1844. 2015.
      16. Vassil A, Pavelecky N, Magnelli A, Videtic G. Chapter 1: General Physics Principles. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM. New York, NY, Demos Medical p. 1-16, 2015.
      17. Weller M, Murphy E. Chapter 12: Pediatric Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM.   New York, NY, Demos Medical. P 201-220. 2015.      
      18. Woody NM, Murphy ES, Stephans KL, Amarnath SA. Chapter 9: Sarcoma Radiotherapy. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM.   New York, NY, Demos Medical. P. 189-200. 2015.      
      19. Woody N, Videtic G. Chapter 2: Tools for Simulation and Treatment. In Handbook of Treatment Planning in Radiation Oncology, 2nd edition. Eds Videtic GMM, Woody NM. New York, NY, Demos Medical. p. 17-26. 2015.

      EDITORS OF TEXTBOOKS:

      1. Videtic GMM, Woody NM. Handbook of Treatment Planning in Radiation Oncology, 2nd edition. New York, NY, Demos Medical.

      ACCEPTED BOOK CHAPTERS:

      1. Angelov L, Chao S, Suh J. Clinical Outcomes of Pain and Quality of Life after Spinal Radiosurgery. Spine Radiosurgery, 2nd Edition, Submitted Nov 2014
      2. Merchant TE, Murphy ES. Radiotherapy of pediatric brain tumors. Principals and Practice of Pediatric Neurosurgery. Jan 2014.
      3. Murphy ES, Merchant TE. Radiotherapy for pediatric CNS malignancies. The International Society of Pediatric Neurosurgeons Guide to Pediatric Neurosurgery. Online publication July 2014.
      4. Okoye C, Patel R, Lo S, Mansur D, Hdeib A, Sahgal A. Chang E, Machtay M, Suh J, Sloan A. Stereotactic Radiosurgery for Pediatric Brain Tumors. Intracranial radiosurgery, 2nd edition. Lunsford D, Sheehan J, eds. Thieme Medical Publishing July 2015
      5. Rizzo AE, Yu JS.       Radiation Therapy for Glioma Stem Cells, In: Ehtesham M, editor. Stem Cell Biology in Neoplasms of the Central Nervous System.       New York: Springer, 2014.
      6. Schroeder J, Suh J, Vogelbaum M, Barnett G. Gliomas.       Intracranial Stereotactic Radiosurgery, 2nd edition. Eds. Lunsford LD, Sheehan JP. New York, NY. Thieme Publishers. July 2015.
      7. Stephans KL, Woody NM, Kotecha R, Videtic GMM. Ch. 33 Treatment planning in thoracic oncology. Treatment planning in radiation oncology, 4th edition. Khan FM, editor. Submitted Sept 2015.
      8. Suh JH, Chao ST, Murphy ES, Weil RJ. Pituitary tumors and craniopharyngiomas. Clinical Radiation Oncology, 4th edition.       Eds. Gunderson L, Tepper J.       Churchhill Livingstone. 2015
      9. Yu JS, Brown M, Suh JH, Ma L, Sahgal A. Radiobiology of Radiotherapy and Radiosurgery. In Winn HR, editor. Youmans Neurological Surgery. 7th ed. Philadelphia: Elsevier Submitted 2014

      ACCEPTED FOR PUBLICATION:

      1. Al-Khudari S, Guo S, Chen Y, Nwizu T, Greskovich JF, Lorenz R, Burkey BB, Adelstein DJ, Koyfman Solitary dural metastasis at presentation in a patient with untreated human papillomavirus associated squamous cell carcinoma of the oropharynx. Head Neck. 2013 Dec 24. E-pub ahead of print
      2. Amoush A, Abdel-Wahab M, Abazeed M, Xia P. Potential Systematic Errors in IGRT When Different Reference Images are Used for Pancreatic Tumors. Accepted to J App Clin Med Phys 2015
      3. Amoush A, Murray E, Yu J, Xia P. Single-isocenter hybrid IMRT plans versus two-isocenter conventional plans and impact of intra-fraction motion for the treatment of breast cancer. J Appl Clin Med Phys 2015
      4. Babcook MA, Sramkoski RM, Fujioka H, Daneshgari F, Almasan A, Shukla S, Nanavaty RR, Gupta S. Combination of simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells. Cell Death & Disease (accepted).
      5. Choudhary GS, Al-Harbi S, Mazumder S, Hill BT, Smith MR, Bodo J, Hsi ED, Almasan A. MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/ mTORC activation in lymphoid malignancies. Cell Death & Disease (accepted).
      6. Fredman ET, Kumar AMS, Abdel-Wahab M. Ten-Year Comparison of 165 Patients treated with IMRT and 3D Conventional Radiation Therapy for Anal Cancer. Gastrointest Cancer Res (Accepted)
      7. Ha D, Choi H; Zell K, Raymond DP, Stephans K, Wang XF, Videtic G, McCarthy K, Minai OA, Mazzone PJ. Association of Impaired Heart Rate Recovery with Cardiopulmonary Complications after Lung Cancer Resection Surgery. Journal of Thoracic and Cardiovascular Surgery. In Press.
      8. Kittel JA, Reddy CA, Smith KL, Stephans KL, Tendulkar RD, Ulchaker J, Angermeier K, Campbell S, Stephenson A, Klein EA, Wilkinson DA, Ciezki JP. Long-Term Efficacy and Toxicity of Low Dose Rate 125I Prostate Brachytherapy as Monotherapy in Low, Intermediate, and High-Risk Prostate Cancer. Accepted.
      9. Klionsky DJ, …Almasan A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy, 2015 (in press).
      10. Kotecha R, Zimmerman A, Murphy ES, Ahmed Z, Ahluwalia MS, Suh JH, Reddy CA, Angelov L, Vogelbaum MA, Barnett GH, Chao ST, Management of brain metastasis in patients with pulmonary neuroendocrine carcinomas. Am J Clin Oncol July 2014.
      11. Kotecha R, Berriochoa CA, Murphy ES, Machado AG, Chao ST, Suh JH, Stephans KL. Whole-Brain Radiation Therapy in Patients with Deep Brain Stimulation Implants: Important Neurosurgical Considerations and Radiotherapy Practice Principles. Accepted J Neurosurg Feb 2015.
      12. Kotecha R, Suh JH. In reply to Dr. Chamberlain. J Clin Oncol 2015.
      13. Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG, Bendszus M, Brown PD, Camidge Dr, Chang SM, Dancey J, de Vries EGE, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wen PY. Proposed Response Assessment Criteria for Brain Metastases: Response Assessment in Neuro-Oncology (RANO) Working Group. Accepted to Lancet Oncol Jan 2015.
      14. Mahmoud OM, Koyfman SA. Re-irradiation for Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck. J Radiation Oncology.
      15. Murphy E, Xie H, Merchant TE, Yu J, Chao ST, Suh JH. Review of cranial radiotherapy-induced vasculopathy.   J Neuro-oncol Feb 2015.
      16. Naik M, Ward M, Bledsoe TJ, Kumar AMS,  Rybicki LA, Saxton JP, Scharpf J, Burkey B, Hoschar AP, Greskovich JF, Adelstein DJ, Koyfman SA. It’s not just IMRT: Human papillomavirus related oropharynx squamous cell carcinoma is associated with better swallowing outcomes after definitive chemoradiotherapy. Accepted Oral Oncol April 2015
      17. Rath GK, Sharma DN, Mallick S, Gandhi AK, Joshi NP, Haresh KP, Gupta S, Julka PK. Clinical outcome of patients with primary gliosarcoma treated with concomitant and adjuvant temozolomide: A single institutional analysis of 27 cases. Accepted Indian Journal Cancer
      18. Robinson CG, Stephans KL. Neoadjuvant chemoradiotherapy for stage III (N2/3) non-small cell lung cancer – a review of prospective studies. Lung Cancer Management 2013, (Accepted)
      19. Rosko A, McColl, Zhong F., Chang MJ, Sattar A, Hill BT, Alharbi S, Almasan A, Distelhorst C. Acidosis sensing receptor GPR65 correlates with anti-apoptotic Bcl-2 family member expression in CLL cells: Potential implications for the CLL microenvironment. J Leukemia 2015 (in press)
      20. Shen Z, Xia P, Klahr P, Djemil T. Dosimetric Impact of Orthopedic Metal Artifact Reduction (O-MAR) on Spine SBRT Patients. Aceepted to Journal of Clinical Applied Medical Physics April 2015
      21. Stockham AL, Koyfman SA, Burdick EA, Reddy CA, Suh JH, Vogelbaum MA, Barnett GH, Chao ST. Validation of the ‘Lesion Quotient’ as a Radiographic Tool to Distinguish between Radiation Necrosis and Tumor Progression for Brain Metastases Treated with Stereotactic Radiosurgery J Neuro-oncol (in press)
      22. Wang Y, Vassil A, Tendulkar R, Bayouth J, Xia P. Application of Non-flat X-ray Photons to Whole Breast Irradiation Using Direct Aperture Optimization. JCAMP.
      23. Weller M, Tendulkar RD, Reddy CA, Stephans KL, Kupelian PA. Adjuvant vs Neoadjuvant Androgen Deprivation with Radiation Therapy for Prostate Cancer: Does Sequencing Matter? Accepted to Clinical Genitourinary Cancer Dec 2014.
      24. Wong RKW, Deshmukh S, Wyatt G, Sagar S, Singh AK, Sultanem K, Nguyen-Tân PF, Yom SS, Cardinale J, Yao M, Hodson I, Matthiesen CL, Suh JH, Thakrar H, Pugh SL, Berk L. Acupuncture-like Transcutaneous Electrical Nerve Stimulation versus Pilocarpine in Treating Early Radiation-Induced Xerostomia: Results of RTOG 0537 Phase 3 Study. Accepted to Int J Radiat Oncol Biol Phys Feb 2015.
      25. Woody NM, Stephans KL, Videtic GMM, Djemil T, Xia P. Potential systemic errors in lung stereotactic body radiation therapy (SBRT) planning and delivery. Accepted to J Radiat Oncol.
      26. Woody NM, Bricker A, Zakem S, Greer M, Joshi N, Koyfman SA. Carotid blowout in a patient treated with nasopharyngeal treated with SBRT re-irradiation for local recurrence using twice weekly treatment. Accepted to J Stereo Radiosurg SBRT. Accepted.
      27. Zimmerman AL, Murphy ES, Suh JH, Vogelbaum MA, Barnett GH, Angelov L, Ahluwalia M, Reddy CA, Chao ST. Treatment of large brain metastases with stereotactic radiosurgery. Tech Cancer Res Treat Jan 2015 [Epub ahead of print]

      SUBMITTED/BEING PREPARED FOR PUBLICATION:

      1. Amoush A, Long H, Subedi L, Qi P, Djemil T, Xia P: Dosimetric Effect of Multileaf Collimator Leaf Width on Volumetric Modulated Arc Stereotactic Radiotherapy for Spine Tumors, under preparation
      2. Berriochoa CA, Videtic GMM, Djemil T, Woody NM, Stephans KL. Lung SBRT for T3N0 tumors with chest wall invasion: Safe and Effective. To be submitted.
      3. Berriochoa CA, Kumar AMS, Khorana AA, Walsh RM, Abdel-Wahab M. Preoperative chemoradiation for locally advanced pancreatic cancer improves margin negativity and nodal involvement at resection. To be submitted.
      4. Buckner JC, Pugh SL, Shaw EG, Gilbert MP, Barger G, Coons S, Ricci P, Bullard D, Brown PD, Stelzer K, Brachman D, Suh JH, Schultz CJ, Bahary J-P, Fisher BJ, Kim H, Murtha AD, Curran WJ Jr., Mehta MP. Long term results of R9802: A Phase III study of radiation therapy (RT) with or without procarbazine, CCNU, and vincristine (PCV) in low-grade glioma. RTOG with Alliance, ECOG-ACRIN and SWOG. Submitted to N Engl Med Nov 2014.
      5. Burkey BB, Han JH, Noble A, Scharpf J, Lamarre E, Khan M, Lorenz RR, Greskovich JF, Koyfman SA. A study of surgically treated early stage tongue cancer:  What can we learn about the role of neck dissection and the implications of an intraoperative positive margin?  JAMA Otolaryngol Head Neck Surg 2014 (Under revision)
      6. Cherian S, Amarnath S, Juliano J. Justin, Saffle P, Rose P, Michener C, Knight J, DeBernardo R, Fleming P. High dose rate interstitial brachytherapy for locally recurrent gynecological tumors, a single institution experience. (In preparation).
      7. Diaconu C, Stephans KL, Djemil T, Videtic GMM, Abdel-Wahab M, Yu N, Greskovich, Jr, J, Xia P. Intra- and Inter-Fraction Reproducibility of Liver and Lung Tumor Localization for Patients Imaged under Active Breathing Control. Med Phys Dec 2013. (revision)
      8. Drzymala R, Alvarez P, Bednarz G, Bourland D, DeWerdL, Ma L, Meltsner S, Neyman G, Novotny J, Petti P, Rivard M, Shiu A, Goetsch S. A Round Robin Gamma Stereotactic Radiosurgery Dosimetry Intercomparison of Calibration Protocols. Submitted to Medical Physics Journal 2014
      9. Fredman ET, Kumar AMS, Coppa C, El-Gazzaz G, Aucejo FN, Abdel-Wahab M. Local Failure after Liver Resection for Hepatocellular Carcinoma. (Submitted to Chinese HBP)
      10. Gladson C, Ahluwalia M, Weil R, Bae E, Huang P, McGraw M, Grove L, Olman M, Kar N, Prayson R, Suh J, Barnett G. Correlation of Higher Levels of Soluble TNF-R2 in Plasma with a Shorter Survival Time in Patients with Recurrent Glioblastoma Tumors - A Pilot Study. J Neurosurg (Submitted)
      11. Glass J, Won M, Schultz CJ, Brat D, Bartlett N, Suh JH, Fisher BJ, Liepmann MK, Mehta MP. RTOG 0227: Phase I/II Study of Pre-Irradiation Chemotherapy with Methotrexate, Rituximab, and Temozolomide and Post-Irradiation Temozolomide for Primary Central Nervous System Lymphoma. Submitted to J Clin Oncol Mar 2015.
      12. Harel R, Emch T, Chao S, Elson P, Krishnaney A, Djemil T, Suh J, Angelov L. Evaluating local control following Surgery and Spinal Radiosurgery (SRS) for Spine Tumors. Submitted to Journal of Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy April 2013.(Submitted)
      13. Hearn JWD, AbuAli G, Magi-Galluzzi C, Reddy CA, Chang K-H, Klein EA, Sharifi N. HSD3B1 and Resistance to Androgen Deprivation Therapy in Prostate Cancer. To be submitted.
      14. Kittel J, Lee J, Woody N, Zimmerman A, Murphy E, Barnett G, Vogelbaum M, Stevens G, Suh J, Chao S. Adjuvant radiation may not be necessary following gross total resection of an atypical meningioma. (in preparation, awaiting data re-analysis, anticipated completion end of May)
      15. Kittel J, Lee J, Kumar AMS, Zimmerman A, Woody N, Murphy E, Barnett G, Stevens G, Recinos PF, Suh J, Chao S. Patients with recurrent atypical meningioma after upfront surgical resection salvaged with radiosurgery require more salvage procedures than patients salvaged with conventional radiation. (in preparation, awaiting data re-analysis, anticipated completion end of May)
      16. Kittel JA, Woody NM, Reddy CA, Oh SC, Pham YD, Ward MC, Djemil T, Stephans KL, Videtic GMM. Is there a Dose-Response Relationship with Stereotactic Body Radiation Therapy for Pulmonary Oligometastases? (anticipated completion Summer 2015)
      17. Kittel JA, Balagamwala EH, Agrawal S, Fung J, Aucejo F, Menon N, Abdel-Wahab M, Stephans K. Stereotactic body radiation therapy for hepatocellular carcinoma. (anticipated completion Fall 2015)
      18. Koyfman S, Joshi N, Vidimos A. Adjuvant radiotherapy in high risk cutaneous squamous cellcncer of the head and neck in immunosuppressed patients. JAAD case report. Submitted Oct 2014.
      19. Joshi N, Rasmussen P, Bain M, Masaryk T, Neyman G, Murphy ES, Chao ST, Suh JH. Large volume cranial arteriovenous malformations: a review. Being prepared.
      20. Joshi N, Rasmussen P, Bain M, Masaryk T, Neyman G, Kotecha R, Murphy ES, Suh JH, Chao ST. Large volume cranial arteriovenous malformations: institutional results with volume staged stereotactic radiosurgery. To be submitted.
      21. Jung EW, Jung DL, Balagamwala EH, Angelov L, Suh JH, Djemil T, Magnelli A, Chao ST. Single fraction spine stereotactic body radiotherapy for treatment of chordoma. To be submitted.
      22. Li W, Vassil A, Godley A, Muhieddine LM, Shang Q, Xia P: Using Daily Diagnostic Quality Images with Online and Offline Shifts to Access Planning Margins for Prostate Cancer. Submitted to Med Phys.
      23. Liu H, Zhuang T, Stephans K, Videtic G, Djemil T, Xia P. Dose Differences in Intensity Modulated Radiotherapy Plans Calculated With Pencil Beam and Monte Carlo for Non-small Cell Lung Cancer. Submitted to JACAMP
      24. Lukovic J, Bourque JM, Abdel-Wahab M. Recurrent rectal cancer: time to re-think re-irradiation? J Radiat Oncol submitted 2014
      25. Kotecha R, Zimmerman A, Murphy ES, Ahmed Z, Ahluwalia MS, Suh JH, Reddy CA, Angelov L, Vogelbaum MA, Barnett GH, Chao ST. Management of brain metastasis in patients with neuroendocrine carcinomas of the lung. Submitted to Tech Ca Res Treat Nov 2014
      26. Koyfman SA, Reddy CA, Hizlan S, Leek AC, Kodish E, on behalf of the Phase I Informed Consent (POIC) Research Team. Informed Consent Conversations and Documents: A Quantitative Comparison. Annals of Internal Medicine. 2014 (Submitted).
      27. Koyfman SA, Cooper JS, Yom SS, Beitler JJ, Busse PM, McDonald MW, Quon H, Ridge JA, Saba NF, Salama JK, Siddiqui F, Smith RV, Worden F, Yao M. American College of Radiology Appropriateness Criteria.: Aggressive Non-melanomatous Skin Cancer of the Head and Neck. (In Preparation)
      28. Koyfman SA, Balagamwala EH, Bledsoe TB, Barnett J, Reddy CA, Nwizu T, Chute D, Saxton JP, Burkey BB, Greskovich JF, Adelstein DJ. Intensity Modulated Radiotherapy Reduces Late Toxicity in Patients with Human Papillomavirus-Associated Oropharyngeal Carcinoma Treated with Chemoradiotherapy. (In-process).
      29. Kumar A, Fredman E, Coppa C, El-Gazzaz G, Aucejo F, Abdel-Wahab. Patterns of failure in localized resected hepatocellular carcinoma- patients with close surgical margins may benefit from adjuvant radiotherapy. J Rad Oncol (Submitted)
      30. Li W, Vassil A, Godley A, Muhieddine Mossolly L, Shang Q, Xia P. Using Daily Diagnostic Quality Images with Online and Offline Shifts to Assess Planning Margins for Prostate Cancer. (To be submitted)
      31. Liu H, Zhuang T, Stephans K, Videtic G, Djemil T, Xia P: Dose Differences in Intensity Modulated Radiotherapy Plans Calculated With Pencil Beam and Monte Carlo for Non-small Cell Lung Cancer, To be re-submitted to Technol Cancer Res Treat, due on 10/2014
      32. Magnelli A, Liu H, Zhong Y, Xia P. Experimental and Clinical Evaluation of a CT Image Reconstruction Algorithm for Metal Artifact Reduction. Submitted to J Applied Clinical Med Phys. (Under revision)
      33. Man J, Shoemake J, Godley A, Ma T, Rizzo A, Wu Q, Rich J, Yu JS. Hyperthermia Overcomes the Radioresistance of Glioblastoma Initiating Cells by Downregulation of AKT Signaling. Cancer Research.
      34. Manyam B, Gastman B, Zhang AY, Reddy CA, Burkey BB, Scharpf J, Alam DS, Fritz MA, Vidimos AT, Koyfman SA. Inferior Outcomes in Immunosuppressed Patients with High Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated with Multimodality Therapy. Journal American Academy Dermatology: 2014 (Submitted)
      35. Manyam B, Mallick I, Abdel-Wahab MM, Reddy CA, Pelley RJ, Remzi FH, Kalady MF, Lavery I, Kiran RP, Koyfman SA. The Impact of Preoperative Radiation Therapy on Locoregional Recurrence in Patients with Stage IV Rectal Cancer Treated with Definitive Surgical Resection and Contemporary Chemotherapy. Journal of Gastrointestinal Surgery. 2014 (Submitted)
      36. Marwaha G, Medina C, Naik M, Ward MC, Wilkinson A, Singh AD. Ruthenium Eye Plaques for Uveal Melanoma: Long-term clinical outcomes. To be submitted to JAMA Opthalmology
      37. Mohammadi AM, Weil RJ, Marko NF, Chao ST, Barnett GH, Vogelbaum MA, Suh JH, Neyman G, Angelov L. Prognostic factors associated with progression free survival and volumetric tumors response after stereotactic radiosurgery in patients with ≥5 brain metastases. Submitted to World Neurosurg Aug 2013. (rejected)
      38. Naik M, Reddy CA, Stephans KL, Tendulkar RD.  Post-Treatment PSA 6 months after Radiation and Androgen Deprivation Therapy Predicts for Distant Metastases and Prostate Cancer Specific Mortality. In Preparation
      39. Naik M, Marta NG, Abdel-Wahab M. Re-irradiation of Locally Recurrent Prostate Cancer After Primary Radiotherapy. Submitted to Journal of Radiation Oncology
      40. Noble A, Han JH, Greskovich JH, Nwizu TH, Adelstein DJ, Reddy CA, Khan CA, Scharpf J, Burkey BB, Koyfman SA. Patterns of Failure and Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative (Chemo)Radiotherapy. Head Neck. 2014 (Submitted)
      41. Moulton L, Nutter B, Cherian S, Rose PG. Does radiation therapy improve survival in patients with uterine clear cell carcinoma undergoing adjuvant chemotherapy? Submitted to Gyn Oncol
      42. Pham YD, Kittel JA, Reddy CA, Ciezki JP, Klein EA, Stephans KL, Tendulkar RD.  Improved Biochemical Control after Permanent Prostate Seed Implantation for Large Prostate Glands > 60 Grams Compared to Smaller Glands.   To be submitted
      43. Qu H, Yu N, Stephans K, Xia P: The Effect of Different Regional Lung Volume Definitions and Breathing Patterns on Lung Ventilation Calculation, submitted to Med. Phys. 9/2014
      44. Russo S, Blackstock AW, Herman J, Abdel-Wahab M, Azad N, Goodman K,. Hong T, Jabbour S, Jones W, Konski A, Koong A, Kumar R, Rodriguez-Bigas M, Small W, Thomas C, Suh W: ACR Appropriateness Criteria Local Excision in Early Stage Rectal Cancer CGR (submitted 2014).
      45. Shang Q, Huang L, Qi P, Xia P. Sensitivity of Gamma Index as a Patient Specific IMRT QA Metric in Detection of MLC Leaf Positioning Errors using MatriXX 2D Array. Submitted to Med. Phys. Sept 2013 (Under revision)
      46. Song A, Kumar A, Murphy E, Suh JH, Reddy C, Peereboom D, Ahluwalia M, Tekautz T, Stevens G, Chao ST. Adult medulloblastoma: optimizing treatment and outcomes. Being prepared for J Neuro-oncol.
      47. Tariq MB, Balagamwala EH, Chao ST. Re-irradiation in central nervous system tumors. J Radiat Oncol. Submitted Aug 2014
      48. Tariq M, Meier T, Suh JH, Reddy C, Godley A, Hugebeck B, Kolar M, Barrett P, Chao ST. Workload may contribute to errors in radiation oncology. Submitted to Pract Radiat Oncol March 2015.
      49. Thibault I, Atenafu EG, Chang E, Chao ST, Al-Omair A, Zhou S, Boehling N, Balagamwala EH, Cunha M, Cho J, Angelov L, Brown PD, Suh JH, Rhines LD, Fehlings MG, Sahgal A. Risk of Vertebral Compression Fracture Specific to Osteolytic Renal Cell Carcinoma Spinal Metastases after Stereotactic Body Radiotherapy: A Multi-Institutional Study. Submitted to Spine July 2014.
      50. Videtic GMM, Hu C, Singh AK, Chang JY, Parker W, Olivier KR, Schild SE, Komaki R, Urbanic JJ, Choy H. RTOG 0915 (NCCTG N0927): A Randomized Phase II Study Comparing 2 Stereotactic Body Radiation Therapy (SBRT) Schedules for Medically Inoperable Patients with Stage I Peripheral Non-Small Cell Lung Cancer. (Submitted)
      51. Vogelbaum MA, Hu C, Peereboom DM, Macdonald DR, Giannini C, Suh JH, Jenkins RB, Laack NN, Brachman DG, Shrieve DC, Souhami L, Mehta MP. Phase II Trial of Pre-Irradiation and Concurrent Temozolomide in Patients with Newly Diagnosed Anaplastic Oligodendrogliomas and Mixed Anaplastic Oligoastrocytomas: Long Term Results of RTOG BR0131. Submitted Aug 2014 to Neuro-oncol.
      52. Ward M, Pham Y, Kotecha R, Zakem S, Greskovich J. Clinical and dosimetric implications of intensity modulated radiotherapy for early stage glottic carcinoma. Submitted to .
      53. Weller MA, Kupelian P, Reddy C, Kotecha R, Ciezki J, Klein E, Stephans K, Tendulkar R. Hypofractionated Intensity-Modulated Radiotherapy for Localized Prostate Cancer: Long Term Outcomes and a Comparison to Standard Dose-Escalated RT.  Submitted Radioth Oncol April 2015.
      54. Weller MA, Ward MC, Berriochoa C, Reddy C, Trosman S, Greskovich J, Nwizu T, Burkey B, Adelstein DJ, Koyfman S. Cetuximab based bioradiotherapy is associated with higher rates of distant metastases than platinum based chemoradiotherapy in HPV positive oropharyngeal cancer. To be submitted May 2015.
      55. Weller MA, Woody NM, Wengler CA, Djohan RS, Schwarz G, Valente SA, Tendulkar RD. Effects of radiotherapy on long term toxicity and reconstruction failure following mastectomy and autologous reconstruction. To be submitted.June 2015.
      56. Wilkinson DA, Kolar MD.  Quality Assurance for Patient Specific HDR Treatment Plans. (Being prepared)
      57. Woody NM, Koyfman SA, Xia P, Yu N, Shang Q, Adelstein DJ, Scharpf J, Burkey B, Saxton JP, Greskovich Jr. JF. Dose de-escalated radiotherapy to involved lymph nodes in HPV positive oropharyngeal cancer is associated with excellent loco-regional control.  Resubmit to Head Neck.
      58. Woody NM, Durand P, Naik M, Coopey SB, Dietz J, Djohan R, Tendulkar RD. Long term outcomes of mastectomy with tissue expander based reconstruction and the effects of radiotherapy and co-morbidities.  To be submitted May 2015.
      59. Yu N, Qu H, Stephans K, Srinivas S, McLennan G, Xia P. Patient Breathing Effect on Liver Y90   Dosimetry Derived From Post-Embolization Y90 PET, to be submitted to the Int J Radiat Oncol Biol Phys. Submitted Radioth Oncol Nov. 2014.
      60. Zhuang TL, Effect of intrafraction motion in a single fraction step-and-shoot IMRT with ablative dose.
      61. Zimmermann L, Amoush A, Wilkinson D:  Episcleral Eye Plaque Dosimetry Comparison for the Eye Physics EP917 Using Plaque Simulator and Monte Carlo Simulation, submitted to Medical Physics

      EXTERNAL PRESENTATIONS:

      Houston Methodist Medical Center Grand Rounds. Houston, TX. Feb 3, 2015

      1. Suh JH. Contemporary management of brain metastases.

      2015 Multidisciplinary Head and Neck Cancer Update, Fort Lauderdale, FL. March 5-7, 2015

      1. Greskovich J. Can we dose de-escalate in favorable HPV-associated oropharynx cancer?  March 6, 2015
      2. Greskovich J. Risk stratification and definitive radiation for early stage laryngeal cancer.  March 7, 2015
      3. Greskovich J. Adjuvant radiation therapy for salivary gland tumors.  March 7, 2015
      4. Joshi N. Management of high risk skin cancer. March 5, 2015
      5. Joshi N. Moderator of panel on oral/skin cancer. March 5. 2015

      8th Annual International Symposium, on Stereotactic Body Radiation Therapy and Stereotactic Radiosurgery. Lake Buena Vista, FL (February 20-22, 2015)

      1. Murphy E. Pediatric brain radiosurgery. February 20, 2015.
      2. Chao S. Radiobiology of Radiosurgery: Response and Radiation Necrosis. February 20, 2015
      3. Chao S. Advances and challenges in the management of spine metastases: Spine SRS. February 20, 2015
      4. Suh J. Radiosurgery Alone vs. Whole Brain Radiation for Multiple Brain Metastases. February 20, 2015
      5. Suh J. How I treat brain metastases and why? February 21, 2015
      6. Suh J. How I Treat - Moderator. February 21, 2015
      7. Tendulkar R. SBRT for genitourinary cancers. February 22, 2015
      8. Stephans K. Lung SBRT: dose response, single fraction, and re-irradiation. February 22, 2015
      9. Stephans K. Lung SBRT. Moderator. February 22, 2015
      10. Chao S. Abdomen and Pelvis- Moderator February 22, 2015

      University of Southern California neurosurgery Grand Rounds. Los Angeles, CA. April 3, 2015

      1. Suh JH. Contemporary management of brain metastases.

      State of the Art Radiation Therapy. Las Vegas, NV. April 10, 2015

      1. Suh JH. Contemporary treatment approaches for brain and spine tumors. State of the Art Radiation Therapy. Las Vegas, NV. April 10, 2015.
      2. Suh JH. CNS clinical and physics aspects of treatment planning: Physician perspective. State of the Art Radiation Therapy. Las Vegas, NV. April 10, 2015.
      3. Suh JH. CNS challenging case panel. State of the Art Radiation Therapy. Las Vegas, NV. April 10, 2015.

      Managing Pituitary Disorders. Cleveland, OH. April 23, 2015

      1. Suh JH. Advances in pituitary radiotherapy. April 23, 2015

      10th Annual Contemporary Issues in Pituitary Disease: Managing persistent and recurrent disorders. Cleveland, OH. April 24, 2015

      1. Suh JH. Radiation treatment of persistent pituitary disease. April 24, 2015.

      Advances in lung cancer: a multidisciplinary approach. Cleveland, OH. April 25, 2015.

      1. Videtic G. Stereotactic body radiotherapy (SBRT) for early stage NSCLC. April 25, 2015
      2. Videtic G. and Stephans K. Radiation Oncology: Role of radiotherapy in lung cancer treatment. April 25, 2015

      ESTRO 2015 (April 24-28).

      1. Cherian S. IORT for pelvic tumors. April 25, 2015

      NIH STUDY SECTIONS/ADVISORY GROUPS:

      1. Almasan A. NCI Special Emphasis Panel ZCA1 RTRB-8 (O1) S Omnibus SEP-7, 06-13-2014
      2. Almasan A. NCI Special Emphasis Panel ZCA1 SRLB-1, “NCI Omnibus Cancer Biology 03-2014.

      GRANTS AWARDED:

      1. Koyfman S. Phase I Dose Escalation Study of Stereotactic Body Radiotherapy (SBRT) for Squamous Cell Carcinoma of the Head and Neck in High Risk Patients Who are Ineligible/Refuse Standard of Care Therapy. EPCRS Grant - $45,360.00
      2. Abazeed M. Precision targeting of therapeutic resistance in non-small cell lung cancer. NIH KL2 Career Development Award. 07/01/2015 – 07/01/2019
      3. Abazeed M. Precision Therapeutics in Squamous Cell Lung.   National Lung Cancer Program. 03/01/2014 - 02/29/2016 - $50,000.             
      4. Abazeed M.  Integrative Radiogenomics in Squamous Cell Lung Cancer. RSNA Research Seed Grant. 07/01/2014 - 06/30/2015  $50,000.             
      5. Abazeed M. Novel Biomarkers of Therapeutic Resistance in Non-Small Cell Lung Cancer. Lung Cancer Research Foundation. 11/01/2014 - 10/31/2015- $50,000              
      6. Koyfman S. Precision Therapeutics in Squamous Cell Cancer of the Head and Neck. Scott Hamilton CARES Initiative Grant.   02/01/2014 – 02/01/2015- $100,000
      7. Peacock C. Patient-derived xenografts as avatars of human small cell lung cancer disease. Scott Hamilton CARES Initiative Grant. 02/01/2015 – 02/01/2016
      8. Yu J. Targeting Glioblastoma Initiating Cells with Thermoradiotherapy and AKT Inhibition. NIH KL2 Mentored Career Development Award, ~$600,000 7/1/14-6/30/18
      9. Yu JS. Autocrine and Paracrine Sema3C Signaling Maintains Glioma Initiating Cells Via Rac1Scott Hamilton CARES Award, $100,000 3/1/14-2/28/15

      VISITING PROFESSORSHIPS:

      1. Suh JH. Houston Methodist Medical Center. Feb 3, 2015
      2. Suh JH. University of Southern California. April 3, 2015

      COURSE DIRECTOR

      1. Greskovich J (Co-director). 2015 Cleveland Clinic Multidisciplinary Head and Neck Cancer Update. Fort Lauderdale, Florida. March 5-7, 2015.
      2. Chao S, Suh J (Co-directors). 8th Annual International Symposium on SBRT and SRS. Lake Buena Vista, FL. Feb 2015
      3. Neyman G, Suh JH (co-directors). Gamma Knife Radiosurgery Course for the Cleveland Clinic
      4. Videtic G. (Co-director). Advances in lung cancer: a multidisciplinary approach. Cleveland, OH. April 25, 2015

      Radium Society 2015 (May 2015)


        Society for Thermal Medicine Annual Conference, Minneapolis, MN


          ASCO-ASTRO GI symposium


            17th International Leksell Gamma Knife Society Meeting in NY (May 11- 15, 2014 )


              ASCO 56th Annual Meeting, Chicago, IL (May 31-June 4, 2014)


                ICE/ENDO Chicago, IL (June 21-24, 2014)


                  AAPM 56th Annual Meeting (July 2014)


                    National Center for Regenerative Medicine Cancer Stem Conference, Cleveland, OH, invited speaker, August 2014


                      ASTRO 56th Annual Meeting in San Francisco, CA. Sept 14-17, 2014


                        60th Annual Meeting of the Radiation Research Society, Las Vegas NV, 09-24-2014


                          Northside Cancer Center, Breast Cancer Symposium, Youngstown, OH, invited speaker, October 2014


                            2014 Penn-Ohio Fall Symposium AAPM Fall Symposium, Cranberry Township, PA, Oct. 17-18,2014


                              2014 CSTRO/SANTRO Symposium, Nanjing, China. Oct 23-25, 2014


                                16th Annual Brain Tumor Update and 4th International Symposium on Long-Term Control of Metastases to the Brain. Las Vegas, NV. November 2014.


                                  Case Western Reserve University DNA Damage & Repair Focus Group Seminar, 11-11-2014


                                    19th Annual SNO Meeting. Miami Beach, Fl. November 13-16, 2014


                                      Markey Cancer Center, University of Kentucky, Lexington, KY, 11-24-2014


                                        RSNA Meeting 2014. Chicago, IL. (November 28- Dec 1, 2014)


                                          Targit Academy. Cleveland, OH (Dec 2014)


                                            TASTRO/TARO 4th Annual Meeting, Taipei, Taiwan, invited speaker, December 2014


                                              RADIATION ONCOLOGY GRAND ROUNDS


                                                Pending Research Support


                                                  GRANTS SUBMITTED:


                                                    INVESTIGATOR-INITIATED TRIALS


                                                      PROSPECTIVE STUDIES/REGISTRIES STARTED 2014


                                                        Cleveland Area Attractions


                                                        The Cleveland Museum of Art

                                                        Newly renovated, The Cleveland Museum of Art features more than 46,000 pieces and work-in-progress galleries.


                                                        The Rock and Roll Hall of Fame and Museum

                                                        The greatest stories and biggest names in rock and roll shine on at the Rock and Roll Hall of Fame, featuring 4 theaters, multiple interactive stations and seven floors of exhibits.

                                                        The Cleveland Metroparks

                                                        Get active and live the outdoor life at the Cleveland Metroparks. Explore over 22,000 acres in 18 reservations.

                                                        The Cleveland Orchestra

                                                        The Cleveland Orchestra is considered one of the nation's best. See a concert at their winter home, Severance Hall, or during summer, listen alfresco at Blossom Music Center.

                                                        The Cleveland Sports Scene

                                                        Catch an Indians, Cavs, or Browns game- just minutes from Cleveland Clinic!

                                                        East 4th Street

                                                        From the best food and entertainment the city has to offer to the coolest address in town to live, East 4th Street is an experience you do not want to miss!

                                                        Ohio City

                                                        Ohio City is considered one of the most diverse and desirable places to live, work, study, play, and worship.

                                                        Playhouse Square

                                                        The largest performance arts center in the nation outside of New York hosts operas, ballets, concerts and Broadway-style musicals.

                                                        The West Side Market

                                                        Catch a glimpse of Cleveland's melting pot heritage at this bustling indoor market where vendors sell fruits, veggies, baked goods and more.

                                                        Cancer Answers & Appointments

                                                        Speak with a cancer nurse specialist for appointment assistance and for answers to your questions about cancer locally at 216.444.7923 or toll-free 1.866.223.8100.

                                                        Monday through Friday from 8 a.m. – 4:30 p.m. (ET).

                                                        Referrals

                                                        Resources for medical professionals

                                                        • Outpatient appointment referrals: 216.444.7923 or 866.223.8100
                                                        • Inpatient hospital transfers: 800.553.5056
                                                        • Referring Physician Concierge: 216.444.6196 or 216.312.4910.

                                                        Clinical Trials

                                                        Search available cancer clinical trials by disease, hospital, phase or number.

                                                        This information is provided by Cleveland Clinic and is not intended to replace the medical advice of your doctor or health care provider. Please consult your health care provider for advice about a specific medical condition.

                                                        © Copyright 2016 Cleveland Clinic. All rights reserved.